<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37317282</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>17</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>Strategies for the Management of Spike Protein-Related Pathology.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1308</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms11051308</ELocationID><Abstract><AbstractText>In the wake of the COVID-19 crisis, a need has arisen to prevent and treat two related conditions, COVID-19 vaccine injury and long COVID-19, both of which can trace at least part of their aetiology to the spike protein, which can cause harm through several mechanisms. One significant mechanism of harm is vascular, and it is mediated by the spike protein, a common element of the COVID-19 illness, and it is related to receiving a COVID-19 vaccine. Given the significant number of people experiencing these two related conditions, it is imperative to develop treatment protocols, as well as to consider the diversity of people experiencing long COVID-19 and vaccine injury. This review summarizes the known treatment options for long COVID-19 and vaccine injury, their mechanisms, and their evidentiary basis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Halma</LastName><ForeName>Matthew T J</ForeName><Initials>MTJ</Initials><AffiliationInfo><Affiliation>EbMCsquared CIC, 11 Laura Place, Bath BA2 4BL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plothe</LastName><ForeName>Christof</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Biophysical Osteopathy, Am Wegweiser 27, 55232 Alzey, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marik</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Front Line COVID-19 Critical Care Alliance (FLCCC), 2001 L St. NW Suite 500, Washington, DC 20036, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawrie</LastName><ForeName>Theresa A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>EbMCsquared CIC, 11 Laura Place, Bath BA2 4BL, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 vaccine injury</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">repurposed medication</Keyword><Keyword MajorTopicYN="N">spike protein</Keyword><Keyword MajorTopicYN="N">thrombosis</Keyword></KeywordList><CoiStatement>M.T.J.H., C.P., and T.A.L. are on the Health and Science Committee of the World Council for Health, a people-centered initiative of the not-for-profit Community Interest Company (CIC) EbMCsquared, for advancing holistic health.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37317282</ArticleId><ArticleId IdType="pmc">PMC10222799</ArticleId><ArticleId IdType="doi">10.3390/microorganisms11051308</ArticleId><ArticleId IdType="pii">microorganisms11051308</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ritchie H., Mathieu E., Rod&#xe9;s-Guirao L., Appel C., Giattino C., Ortiz-Ospina E., Hasell J., Macdonald B., Beltekian D., Roser M. Coronavirus Pandemic (COVID-19). Our World in Data 2020.  [(accessed on 1 October 2022)].  Available online:  https://ourworldindata.org/coronavirus.</Citation></Reference><Reference><Citation>Staff G. COVID-19 Vaccine Production to January 31st 2022.  [(accessed on 1 October 2022)].  Available online:  https://globalcommissionforpostpandemicpolicy.org/covid-19-vaccine-production-to-january-31st-2022/</Citation></Reference><Reference><Citation>Halma M.T.J., Rose J., Lawrie T. The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review. J. 2023;6:220&#x2013;235. doi: 10.3390/j6020017.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/j6020017</ArticleId></ArticleIdList></Reference><Reference><Citation>ARCHIVE: Conditions of Authorisation for COVID-19 Vaccine Pfizer/BioNTech (Regulation 174)  [(accessed on 1 October 2022)]; Available online:  https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/conditions-of-authorisation-for-pfizerbiontech-covid-19-vaccine.</Citation></Reference><Reference><Citation>Ball P. The Lightning-Fast Quest for COVID Vaccines&#x2014;and What It Means for Other Diseases. Nature. 2020;589:16&#x2013;18. doi: 10.1038/d41586-020-03626-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-03626-1</ArticleId><ArticleId IdType="pubmed">33340018</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand P., Stahel V.P. Review the Safety of COVID-19 MRNA Vaccines: A Review. Patient Saf. Surg. 2021;15:20. doi: 10.1186/s13037-021-00291-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13037-021-00291-9</ArticleId><ArticleId IdType="pmc">PMC8087878</ArticleId><ArticleId IdType="pubmed">33933145</ArticleId></ArticleIdList></Reference><Reference><Citation>Doshi P. COVID-19 Vaccines: In the Rush for Regulatory Approval, Do We Need More Data? BMJ. 2021;373:n1244. doi: 10.1136/bmj.n1244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1244</ArticleId><ArticleId IdType="pubmed">34006591</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond&#xec; M.L., Di Ges&#xf9; R., Craparo E.F. Chapter Twelve&#x2014;Lipid Nanoparticles for Drug Targeting to the Brain. In: D&#xfc;zg&#xfc;ne&#x15f; N., editor. Methods in Enzymology. Volume 508. Academic Press; Cambridge, MA, USA: 2012. pp. 229&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pubmed">22449929</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottoo F.H., Sharma S., Javed M.N., Barkat M.A., Harshita, Alam M.S., Naim M.J., Alam O., Ansari M.A., Barreto G.E., et al. Lipid-Based Nanoformulations in the Treatment of Neurological Disorders. Drug. Metab. Rev. 2020;52:185&#x2013;204. doi: 10.1080/03602532.2020.1726942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03602532.2020.1726942</ArticleId><ArticleId IdType="pubmed">32116044</ArticleId></ArticleIdList></Reference><Reference><Citation>Akinc A., Maier M.A., Manoharan M., Fitzgerald K., Jayaraman M., Barros S., Ansell S., Du X., Hope M.J., Madden T.D., et al. The Onpattro Story and the Clinical Translation of Nanomedicines Containing Nucleic Acid-Based Drugs. Nat. Nanotechnol. 2019;14:1084&#x2013;1087. doi: 10.1038/s41565-019-0591-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41565-019-0591-y</ArticleId><ArticleId IdType="pubmed">31802031</ArticleId></ArticleIdList></Reference><Reference><Citation>Thacker P.D. COVID-19: Researcher Blows the Whistle on Data Integrity Issues in Pfizer&#x2019;s Vaccine Trial. BMJ. 2021;375:n2635. doi: 10.1136/bmj.n2635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n2635</ArticleId><ArticleId IdType="pubmed">34728500</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata A.F., Cheng C.-A., Desjardins M., Senussi Y., Sherman A.C., Powell M., Novack L., Von S., Li X., Baden L.R., et al. Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of MRNA-1273 Vaccine Recipients. Clin. Infect. Dis. 2022;74:715&#x2013;718. doi: 10.1093/cid/ciab465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab465</ArticleId><ArticleId IdType="pmc">PMC8241425</ArticleId><ArticleId IdType="pubmed">34015087</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal S., Perincheri S., Fleming T., Poulson C., Tiffany B., Bremner R.M., Mohanakumar T. Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer&#x2013;BioNTech) Vaccination Prior to Development of Antibodies: A Novel Mechanism for Immune Activation by MRNA Vaccines. J. Immunol. 2021;207:2405&#x2013;2410. doi: 10.4049/jimmunol.2100637.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2100637</ArticleId><ArticleId IdType="pmc">PMC11073804</ArticleId><ArticleId IdType="pubmed">34654691</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;ltgen K., Nielsen S.C.A., Silva O., Younes S.F., Zaslavsky M., Costales C., Yang F., Wirz O.F., Solis D., Hoh R.A., et al. Immune Imprinting, Breadth of Variant Recognition, and Germinal Center Response in Human SARS-CoV-2 Infection and Vaccination. Cell. 2022;185:1025&#x2013;1040.e14. doi: 10.1016/j.cell.2022.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.018</ArticleId><ArticleId IdType="pmc">PMC8786601</ArticleId><ArticleId IdType="pubmed">35148837</ArticleId></ArticleIdList></Reference><Reference><Citation>Spike Protein Behavior.  [(accessed on 1 October 2022)].  Available online:  https://www.science.org/content/blog-post/spike-protein-behavior.</Citation></Reference><Reference><Citation>Schlake T., Thess A., Fotin-Mleczek M., Kallen K.-J. Developing MRNA-Vaccine Technologies. RNA Biol. 2012;9:1319&#x2013;1330. doi: 10.4161/rna.22269.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rna.22269</ArticleId><ArticleId IdType="pmc">PMC3597572</ArticleId><ArticleId IdType="pubmed">23064118</ArticleId></ArticleIdList></Reference><Reference><Citation>Shyu A.-B., Wilkinson M.F., van Hoof A. Messenger RNA Regulation: To Translate or to Degrade. EMBO J. 2008;27:471&#x2013;481. doi: 10.1038/sj.emboj.7601977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7601977</ArticleId><ArticleId IdType="pmc">PMC2241649</ArticleId><ArticleId IdType="pubmed">18256698</ArticleId></ArticleIdList></Reference><Reference><Citation>Baudrimont A., Voegeli S., Viloria E.C., Stritt F., Lenon M., Wada T., Jaquet V., Becskei A. Multiplexed Gene Control Reveals Rapid MRNA Turnover. Sci. Adv. 2017;3:e1700006. doi: 10.1126/sciadv.1700006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1700006</ArticleId><ArticleId IdType="pmc">PMC5507631</ArticleId><ArticleId IdType="pubmed">28706991</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B., Francisco E., Yogendra R., Long E., Pise A., Beaty C., Osgood E., Bream J., Kreimer M., Heide R.V., et al. SARS-CoV-2 S1 Protein Persistence in SARS-CoV-2 Negative Post-Vaccination Individuals with Long COVID/PASC-Like Symptoms. Res. Sq. 2022:Preprint. doi: 10.21203/rs.3.rs-1844677/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1844677/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Francisco E.B., Yogendra R., Long E., Pise A., Rodrigues H., Hall E., Herrera M., Parikh P., Guevara-Coto J., et al. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection. Front. Immunol. 2022;12:5526. doi: 10.3389/fimmu.2021.746021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S., Shafiei M.S., Longoria C., Schoggins J.W., Savani R.C., Zaki H. SARS-CoV-2 Spike Protein Induces Inflammation via TLR2-Dependent Activation of the NF-&#x39a;B Pathway. Elife. 2021;10:e68563. doi: 10.7554/eLife.68563.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.68563</ArticleId><ArticleId IdType="pmc">PMC8709575</ArticleId><ArticleId IdType="pubmed">34866574</ArticleId></ArticleIdList></Reference><Reference><Citation>Robles J.P., Zamora M., Adan-Castro E., Siqueiros-Marquez L., Martinez de la Escalera G., Clapp C. The Spike Protein of SARS-CoV-2 Induces Endothelial Inflammation through Integrin A5&#x3b2;1 and NF-&#x39a;B Signaling. J. Biol. Chem. 2022;298:101695. doi: 10.1016/j.jbc.2022.101695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2022.101695</ArticleId><ArticleId IdType="pmc">PMC8820157</ArticleId><ArticleId IdType="pubmed">35143839</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks W.A., Sharma P., Bullock K.M., Hansen K.M., Ludwig N., Whiteside T.L. Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation. Int. J. Mol. Sci. 2020;21:4407. doi: 10.3390/ijms21124407.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21124407</ArticleId><ArticleId IdType="pmc">PMC7352415</ArticleId><ArticleId IdType="pubmed">32575812</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.Y., Syed A.M., MacMillan P., Rocheleau J.V., Chan W.C.W. Flow Rate Affects Nanoparticle Uptake into Endothelial Cells. Adv. Mater. 2020;32:e1906274. doi: 10.1002/adma.201906274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adma.201906274</ArticleId><ArticleId IdType="pubmed">32383233</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan T.P., DeOre B.J., Baldwin-Leclair A., Bullock T.A., McGary H.M., Khan J.A., Razmpour R., Hale J.F., Galie P.A., Potula R., et al. The SARS-CoV-2 Spike Protein Alters Barrier Function in 2D Static and 3D Microfluidic in-Vitro Models of the Human Blood-Brain Barrier. Neurobiol. Dis. 2020;146:105131. doi: 10.1016/j.nbd.2020.105131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105131</ArticleId><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Asandei A., Mereuta L., Schiopu I., Park J., Seo C.H., Park Y., Luchian T. Non-Receptor-Mediated Lipid Membrane Permeabilization by the SARS-CoV-2 Spike Protein S1 Subunit. ACS Appl. Mater. Interfaces. 2020;12:55649&#x2013;55658. doi: 10.1021/acsami.0c17044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsami.0c17044</ArticleId><ArticleId IdType="pubmed">33270413</ArticleId></ArticleIdList></Reference><Reference><Citation>Malhotra A. Curing the Pandemic of Misinformation on COVID-19 MRNA Vaccines through Real Evidence-Based Medicine&#x2014;Part 1. J. Insul. Resist. 2022;5:8. doi: 10.4102/jir.v5i1.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.4102/jir.v5i1.71</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill J.R., Tashjian R., Duncanson E. Autopsy Histopathologic Cardiac Findings in 2 Adolescents Following the Second COVID-19 Vaccine Dose. Arch. Pathol. Lab. Med. 2022;146:925&#x2013;929. doi: 10.5858/arpa.2021-0435-SA.</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/arpa.2021-0435-SA</ArticleId><ArticleId IdType="pubmed">35157759</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz G.A., Parsons G.T., Gering S.K., Meier A.R., Hutchinson I.V., Robicsek A. Myocarditis and Pericarditis After Vaccination for COVID-19. JAMA. 2021;326:1210&#x2013;1212. doi: 10.1001/jama.2021.13443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.13443</ArticleId><ArticleId IdType="pmc">PMC8340007</ArticleId><ArticleId IdType="pubmed">34347001</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlstad &#xd8;., Hovi P., Husby A., H&#xe4;rk&#xe4;nen T., Selmer R.M., Pihlstr&#xf6;m N., Hansen J.V., Nohynek H., Gunnes N., Sundstr&#xf6;m A., et al. SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents. JAMA Cardiol. 2022;7:600&#x2013;612. doi: 10.1001/jamacardio.2022.0583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2022.0583</ArticleId><ArticleId IdType="pmc">PMC9021987</ArticleId><ArticleId IdType="pubmed">35442390</ArticleId></ArticleIdList></Reference><Reference><Citation>Patone M., Mei X.W., Handunnetthi L., Dixon S., Zaccardi F., Shankar-Hari M., Watkinson P., Khunti K., Harnden A., Coupland C.A.C., et al. Risks of Myocarditis, Pericarditis, and Cardiac Arrhythmias Associated with COVID-19 Vaccination or SARS-CoV-2 Infection. Nat. Med. 2022;28:410&#x2013;422. doi: 10.1038/s41591-021-01630-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01630-0</ArticleId><ArticleId IdType="pmc">PMC8863574</ArticleId><ArticleId IdType="pubmed">34907393</ArticleId></ArticleIdList></Reference><Reference><Citation>Kracalik I., Oster M.E., Broder K.R., Cortese M.M., Glover M., Shields K., Creech C.B., Romanson B., Novosad S., Soslow J., et al. Outcomes at Least 90 Days since Onset of Myocarditis after MRNA COVID-19 Vaccination in Adolescents and Young Adults in the USA: A Follow-up Surveillance Study. Lancet Child Adolesc. Health. 2022;6:788&#x2013;798. doi: 10.1016/S2352-4642(22)00244-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00244-9</ArticleId><ArticleId IdType="pmc">PMC9555956</ArticleId><ArticleId IdType="pubmed">36152650</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansanguan S., Charunwatthana P., Piyaphanee W., Dechkhajorn W., Poolcharoen A., Mansanguan C. Cardiovascular Manifestation of the BNT162b2 MRNA COVID-19 Vaccine in Adolescents. Trop. Med. Infect. Dis. 2022;7:196. doi: 10.3390/tropicalmed7080196.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed7080196</ArticleId><ArticleId IdType="pmc">PMC9414075</ArticleId><ArticleId IdType="pubmed">36006288</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai W., He L., Zhang X., Pu J., Voronin D., Jiang S., Zhou Y., Du L. Characterization of the Receptor-Binding Domain (RBD) of 2019 Novel Coronavirus: Implication for Development of RBD Protein as a Viral Attachment Inhibitor and Vaccine. Cell Mol. Immunol. 2020;17:613&#x2013;620. doi: 10.1038/s41423-020-0400-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0400-4</ArticleId><ArticleId IdType="pmc">PMC7091888</ArticleId><ArticleId IdType="pubmed">32203189</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C.B., Farzan M., Chen B., Choe H. Mechanisms of SARS-CoV-2 Entry into Cells. Nat. Rev. Mol. Cell Biol. 2022;23:3&#x2013;20. doi: 10.1038/s41580-021-00418-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin Y.-H., Jeong K., Lee J., Lee H.J., Yim J., Kim J., Kim S., Park S.B. Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry. Angew. Chem. Int. Ed. Engl. 2022;61:e202115695. doi: 10.1002/anie.202115695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.202115695</ArticleId><ArticleId IdType="pmc">PMC9011661</ArticleId><ArticleId IdType="pubmed">35043545</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Flores D., Zepeda-Cervantes J., Cruz-Res&#xe9;ndiz A., Aguirre-Sampieri S., Sampieri A., Vaca L. SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants. Front. Immunol. 2021;12:701501. doi: 10.3389/fimmu.2021.701501.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.701501</ArticleId><ArticleId IdType="pmc">PMC8311925</ArticleId><ArticleId IdType="pubmed">34322129</ArticleId></ArticleIdList></Reference><Reference><Citation>Read A.F., Baigent S.J., Powers C., Kgosana L.B., Blackwell L., Smith L.P., Kennedy D.A., Walkden-Brown S.W., Nair V.K. Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens. PLoS Biol. 2015;13:e1002198. doi: 10.1371/journal.pbio.1002198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1002198</ArticleId><ArticleId IdType="pmc">PMC4516275</ArticleId><ArticleId IdType="pubmed">26214839</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyngse F.P., Kirkeby C.T., Denwood M., Christiansen L.E., M&#xf8;lbak K., M&#xf8;ller C.H., Skov R.L., Krause T.G., Rasmussen M., Sieber R.N., et al. Household Transmission of SARS-CoV-2 Omicron Variant of Concern Subvariants BA.1 and BA.2 in Denmark. Nat. Commun. 2022;13:5760. doi: 10.1038/s41467-022-33498-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33498-0</ArticleId><ArticleId IdType="pmc">PMC9524324</ArticleId><ArticleId IdType="pubmed">36180438</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Cort&#xe9;s G.I., Palacios-P&#xe9;rez M., Zamudio G.S., Veled&#xed;az H.F., Ortega E., Jos&#xe9; M.V. Neutral Evolution Test of the Spike Protein of SARS-CoV-2 and Its Implications in the Binding to ACE2. Sci. Rep. 2021;11:18847. doi: 10.1038/s41598-021-96950-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-96950-z</ArticleId><ArticleId IdType="pmc">PMC8458503</ArticleId><ArticleId IdType="pubmed">34552110</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta D., Sharma P., Singh M., Kumar M., Ethayathulla A.S., Kaur P. Structural and Functional Insights into the Spike Protein Mutations of Emerging SARS-CoV-2 Variants. Cell Mol. Life Sci. 2021;78:7967&#x2013;7989. doi: 10.1007/s00018-021-04008-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-021-04008-0</ArticleId><ArticleId IdType="pmc">PMC11073194</ArticleId><ArticleId IdType="pubmed">34731254</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major Findings, Mechanisms and Recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumtaz A., Sheikh A.A.E., Khan A.M., Khalid S.N., Khan J., Nasrullah A., Sagheer S., Sheikh A.B. COVID-19 Vaccine and Long COVID: A Scoping Review. Life. 2022;12:1066. doi: 10.3390/life12071066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12071066</ArticleId><ArticleId IdType="pmc">PMC9324565</ArticleId><ArticleId IdType="pubmed">35888154</ArticleId></ArticleIdList></Reference><Reference><Citation>Loh E.-W. Dose-Response Study a Glucoside- and Rutinoside-Rich Crude Material in Relieving Side Effects of COVID-19 Vaccines.  [(accessed on 30 September 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT05387252.</Citation></Reference><Reference><Citation>University of Oxford  Characterisation of the Effects of Spermidine, a Nutrition Supplement, on the Immune Memory Response to Coronavirus Vaccine in Older People.  [(accessed on 30 September 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT05421546.</Citation></Reference><Reference><Citation>Universit&#xe9; de Sherbrooke  Modulation of Immune Responses to COVID-19 Vaccination by an Intervention on the Gut Microbiota: A Randomized Controlled Trial.  [(accessed on 30 September 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT05195151.</Citation></Reference><Reference><Citation>AB Biotek  Efficacy and Tolerability of a Nutritional Supplementation With ABBC-1, a Symbiotic Combination of Beta-Glucans and Selenium and Zinc Enriched Probiotics, in Volunteers Receiving the Influenza or the COVID-19 Vaccines.  [(accessed on 30 September 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT04798677.</Citation></Reference><Reference><Citation>Maastricht University Medical Center  The Effect of Plant Stanol Ester Consumption on the Vaccination Response to a COVID-19 Vaccine.  [(accessed on 30 September 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT04844346.</Citation></Reference><Reference><Citation>Saxe G. Multicenter Double-Blind, Placebo-Controlled RCT of Fomitopsis Officinalis/Trametes Versicolor for COVID-19.  [(accessed on 30 September 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT04951336.</Citation></Reference><Reference><Citation>Eng&#x131;nden&#x131;z Z. Evaluation of Deltoid Muscle Exercises on Injection Site and Arm Pain After Pfizer&#x2014;BioNTech (BNT162b2) COVID-19 Vaccination, A Randomized Controlled Study.  [(accessed on 30 September 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT05157230.</Citation></Reference><Reference><Citation>Sanchez J. Augmentation of Immune Response to COVID-19 MRNA Vaccination through Osteopathic Manipulative Treatment Including Lymphatic Pumps.  [(accessed on 30 September 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT04928456.</Citation></Reference><Reference><Citation>Rowan University  Lymphatic Osteopathic Manipulative Medicine to Enhance COVID-19 Vaccination Efficacy.  [(accessed on 30 September 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT05069636.</Citation></Reference><Reference><Citation>Bartley J. Vaccination Efficacy With Metformin in Older Adults: A Pilot Study.  [(accessed on 30 September 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT03996538.</Citation></Reference><Reference><Citation>Karanja P.S. Iron and Vaccine-Preventable Viral Disease.  [(accessed on 30 September 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT04912661.</Citation></Reference><Reference><Citation>Materia Medica Holding  Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Clinical Trial to Evaluate the Efficacy and Safety of Ergoferon as Non-Specific COVID-19 Prevention During Vaccination Against SARS-CoV-2.  [(accessed on 30 September 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT05069649.</Citation></Reference><Reference><Citation>Gnessi L. COVID-19 Vaccination in Subjects With Obesity: Impact of Metabolic Health and the Role of a Ketogenic Diet.  [(accessed on 30 September 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT05163743.</Citation></Reference><Reference><Citation>Wang A.X. Impact of Immunosuppression Adjustment on the Immune Response to SARS-CoV-2 MRNA Vaccination in Kidney Transplant Recipients (ADIVKT)  [(accessed on 30 September 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT05060991.</Citation></Reference><Reference><Citation>University Hospital Inselspital, Berne  Registry Study for COVID19 Vaccination Efficacy in Patients With a Treatment History of Rituximab.  [(accessed on 30 September 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT04877496.</Citation></Reference><Reference><Citation>Webster K.E., O&#x2019;Byrne L., MacKeith S., Philpott C., Hopkins C., Burton M.J. Interventions for the Prevention of Persistent Post-COVID-19 Olfactory Dysfunction. Cochrane Database Syst. Rev. 2021;2021:CD013877. doi: 10.1002/14651858.CD013877.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013877.pub2</ArticleId><ArticleId IdType="pmc">PMC8406518</ArticleId><ArticleId IdType="pubmed">34291812</ArticleId></ArticleIdList></Reference><Reference><Citation>Fertig T.E., Chitoiu L., Marta D.S., Ionescu V.-S., Cismasiu V.B., Radu E., Angheluta G., Dobre M., Serbanescu A., Hinescu M.E., et al. Vaccine MRNA Can Be Detected in Blood at 15 Days Post-Vaccination. Biomedicines. 2022;10:1538. doi: 10.3390/biomedicines10071538.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10071538</ArticleId><ArticleId IdType="pmc">PMC9313234</ArticleId><ArticleId IdType="pubmed">35884842</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahl K., Senn J.J., Yuzhakov O., Bulychev A., Brito L.A., Hassett K.J., Laska M.E., Smith M., Almarsson &#xd6;., Thompson J., et al. Preclinical and Clinical Demonstration of Immunogenicity by MRNA Vaccines against H10N8 and H7N9 Influenza Viruses. Mol. Ther. 2017;25:1316&#x2013;1327. doi: 10.1016/j.ymthe.2017.03.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2017.03.035</ArticleId><ArticleId IdType="pmc">PMC5475249</ArticleId><ArticleId IdType="pubmed">28457665</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna N., Heffes-Doon A., Lin X., Manzano De Mejia C., Botros B., Gurzenda E., Nayak A. Detection of Messenger RNA COVID-19 Vaccines in Human Breast Milk. JAMA Pediatr. 2022;176:1268. doi: 10.1001/jamapediatrics.2022.3581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.3581</ArticleId><ArticleId IdType="pmc">PMC9513706</ArticleId><ArticleId IdType="pubmed">36156636</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuovo G.J., Magro C., Shaffer T., Awad H., Suster D., Mikhail S., He B., Michaille J.-J., Liechty B., Tili E. Endothelial Cell Damage Is the Central Part of COVID-19 and a Mouse Model Induced by Injection of the S1 Subunit of the Spike Protein. Ann. Diagn. Pathol. 2021;51:151682. doi: 10.1016/j.anndiagpath.2020.151682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anndiagpath.2020.151682</ArticleId><ArticleId IdType="pmc">PMC7758180</ArticleId><ArticleId IdType="pubmed">33360731</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghavan S., Kenchappa D.B., Leo M.D. SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity. Front. Cardiovasc. Med. 2021;8:687783. doi: 10.3389/fcvm.2021.687783.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.687783</ArticleId><ArticleId IdType="pmc">PMC8225996</ArticleId><ArticleId IdType="pubmed">34179146</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y., Zhang J., Schiavon C.R., He M., Chen L., Shen H., Zhang Y., Yin Q., Cho Y., Andrade L., et al. SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2. Circ. Res. 2021;128:1323&#x2013;1326. doi: 10.1161/CIRCRESAHA.121.318902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.318902</ArticleId><ArticleId IdType="pmc">PMC8091897</ArticleId><ArticleId IdType="pubmed">33784827</ArticleId></ArticleIdList></Reference><Reference><Citation>Serviente C., Matias A., Erol M.E., Calderone M., Layec G. The Influence of COVID-19-Based MRNA Vaccines on Measures of Conduit Artery and Microvascular Endothelial Function. FASEB J. 2022;36 doi: 10.1096/fasebj.2022.36.S1.R2199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.2022.36.S1.R2199</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus-de Jong C., Cleemput I., Van den Heede K. Pathophysiology and Mechanism of Long COVID: A Comprehensive Review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long Covid-Mechanisms, Risk Factors, and Management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-Term Cardiovascular Outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Bluemke D.A., L&#xfc;scher T.F., Neubauer S. Long COVID: Post-Acute Sequelae of COVID-19 with a Cardiovascular Focus. Eur. Heart J. 2022;43:1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker L.M., Swank Z., Bartsch Y.C., Burns M.D., Kane A., Boribong B.P., Davis J.P., Loiselle M., Novak T., Senussi Y., et al. Circulating Spike Protein Detected in Post&#x2013;COVID-19 MRNA Vaccine Myocarditis. Circulation. 2023;147:867&#x2013;876. doi: 10.1161/CIRCULATIONAHA.122.061025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.061025</ArticleId><ArticleId IdType="pmc">PMC10010667</ArticleId><ArticleId IdType="pubmed">36597886</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Liu Y., Wang X., Yang L., Li H., Wang Y., Liu M., Zhao X., Xie Y., Yang Y., et al. SARS-CoV-2 Binds Platelet ACE2 to Enhance Thrombosis in COVID-19. J. Hematol. Oncol. 2020;13:120. doi: 10.1186/s13045-020-00954-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-020-00954-7</ArticleId><ArticleId IdType="pmc">PMC7471641</ArticleId><ArticleId IdType="pubmed">32887634</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar L.M., Venter C., Vlok M., Ngoepe M., Laubscher G.J., Lourens P.J., Steenkamp J., Kell D.B., Pretorius E. SARS-CoV-2 Spike Protein S1 Induces Fibrin(Ogen) Resistant to Fibrinolysis: Implications for Microclot Formation in COVID-19. Biosci. Rep. 2021;41:BSR20210611. doi: 10.1042/BSR20210611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210611</ArticleId><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Nystr&#xf6;m S., Hammarstr&#xf6;m P. Amyloidogenesis of SARS-CoV-2 Spike Protein. J. Am. Chem. Soc. 2022;144:8945&#x2013;8950. doi: 10.1021/jacs.2c03925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.2c03925</ArticleId><ArticleId IdType="pmc">PMC9136918</ArticleId><ArticleId IdType="pubmed">35579205</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery J., Ryan M., Engler R., Hoffman D., McClenathan B., Collins L., Loran D., Hrncir D., Herring K., Platzer M., et al. Myocarditis Following Immunization With MRNA COVID-19 Vaccines in Members of the US Military. JAMA Cardiol. 2021;6:1202&#x2013;1206. doi: 10.1001/jamacardio.2021.2833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.2833</ArticleId><ArticleId IdType="pmc">PMC8243257</ArticleId><ArticleId IdType="pubmed">34185045</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty C., Bhattacharya M., Sharma A.R. Present Variants of Concern and Variants of Interest of Severe Acute Respiratory Syndrome Coronavirus 2: Their Significant Mutations in S-Glycoprotein, Infectivity, Re-Infectivity, Immune Escape and Vaccines Activity. Rev. Med. Virol. 2022;32:e2270. doi: 10.1002/rmv.2270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2270</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey W.T., Carabelli A.M., Jackson B., Gupta R.K., Thomson E.C., Harrison E.M., Ludden C., Reeve R., Rambaut A., Peacock S.J., et al. SARS-CoV-2 Variants, Spike Mutations and Immune Escape. Nat. Rev. Microbiol. 2021;19:409&#x2013;424. doi: 10.1038/s41579-021-00573-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00573-0</ArticleId><ArticleId IdType="pmc">PMC8167834</ArticleId><ArticleId IdType="pubmed">34075212</ArticleId></ArticleIdList></Reference><Reference><Citation>Collier A.Y., Miller J., Hachmann N.P., McMahan K., Liu J., Bondzie E.A., Gallup L., Rowe M., Schonberg E., Thai S., et al. Immunogenicity of BA.5 Bivalent MRNA Vaccine Boosters. N. Engl. J. Med. 2023;388:565&#x2013;567. doi: 10.1056/NEJMc2213948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2213948</ArticleId><ArticleId IdType="pmc">PMC9847505</ArticleId><ArticleId IdType="pubmed">36630611</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J.-H., Patel N., Haupt R., Zhou H., Weston S., Hammond H., Logue J., Portnoff A.D., Norton J., Guebre-Xabier M., et al. SARS-CoV-2 Spike Glycoprotein Vaccine Candidate NVX-CoV2373 Immunogenicity in Baboons and Protection in Mice. Nat. Commun. 2021;12:372. doi: 10.1038/s41467-020-20653-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20653-8</ArticleId><ArticleId IdType="pmc">PMC7809486</ArticleId><ArticleId IdType="pubmed">33446655</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty C., Sharma A.R., Bhattacharya M., Lee S.-S. A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations. Front. Immunol. 2022;13:801522. doi: 10.3389/fimmu.2022.801522.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.801522</ArticleId><ArticleId IdType="pmc">PMC8863680</ArticleId><ArticleId IdType="pubmed">35222380</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan Y., Shang J., Sun S., Tai W., Chen J., Geng Q., He L., Chen Y., Wu J., Shi Z., et al. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry. J. Virol. 2020;94:e02015-19. doi: 10.1128/JVI.02015-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02015-19</ArticleId><ArticleId IdType="pmc">PMC7022351</ArticleId><ArticleId IdType="pubmed">31826992</ArticleId></ArticleIdList></Reference><Reference><Citation>Regev-Yochay G., Gonen T., Gilboa M., Mandelboim M., Indenbaum V., Amit S., Meltzer L., Asraf K., Cohen C., Fluss R., et al. Efficacy of a Fourth Dose of COVID-19 MRNA Vaccine against Omicron. N. Engl. J. Med. 2022;386:1377&#x2013;1380. doi: 10.1056/NEJMc2202542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2202542</ArticleId><ArticleId IdType="pmc">PMC9006792</ArticleId><ArticleId IdType="pubmed">35297591</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Wang J., Xu J., Xia H., Wang Y., Zhang C., Chen W., Zhang H., Liu Q., Zhu R., et al. Comprehensive Investigations Revealed Consistent Pathophysiological Alterations after Vaccination with COVID-19 Vaccines. Cell Discov. 2021;7:99. doi: 10.1038/s41421-021-00329-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00329-3</ArticleId><ArticleId IdType="pmc">PMC8546144</ArticleId><ArticleId IdType="pubmed">34697287</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Cuthbertson D.J., Wootton D., Crooks M., Gabbay M., Eichert N., Mouchti S., Pansini M., Roca-Fernandez A., Thomaides-Brears H., et al. Multi-Organ Impairment and Long COVID: A 1-Year Prospective, Longitudinal Cohort Study. J. R. Soc. Med. 2023;116:97&#x2013;112. doi: 10.1177/01410768231154703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768231154703</ArticleId><ArticleId IdType="pmc">PMC10041626</ArticleId><ArticleId IdType="pubmed">36787802</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafa Alhussein M., Rabbani M., Sarak B., Dykstra S., Labib D., Flewitt J., Lydell C.P., Howarth A.G., Filipchuck N., Kealey A., et al. Natural History of Myocardial Injury After COVID-19 Vaccine&#x2013;Associated Myocarditis. Can. J. Cardiol. 2022;38:1676&#x2013;1683. doi: 10.1016/j.cjca.2022.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2022.07.017</ArticleId><ArticleId IdType="pmc">PMC9356639</ArticleId><ArticleId IdType="pubmed">35944800</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott M.G., Allawi Z., Hofer M., Ansorge O., Brady S., Fadic R., Torres G., Knight R., Calvo M., Bennett D.L.H., et al. Acute Small Fiber Neuropathy after Oxford-AstraZeneca ChAdOx1-S Vaccination: A Report of Three Cases and Review of the Literature. J. Peripher. Nerv. Syst. 2022;27:325&#x2013;329. doi: 10.1111/jns.12509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jns.12509</ArticleId><ArticleId IdType="pmc">PMC9538519</ArticleId><ArticleId IdType="pubmed">35962630</ArticleId></ArticleIdList></Reference><Reference><Citation>Khokhar F., Khan A., Hussain Z., Yu J. Small Fiber Neuropathy Associated With the Moderna SARS-CoV-2 Vaccine. Cureus. 2022;14:e25969. doi: 10.7759/cureus.25969.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.25969</ArticleId><ArticleId IdType="pmc">PMC9259076</ArticleId><ArticleId IdType="pubmed">35812635</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Tamborska A.A., Doheim M.F., Garcia-Azorin D., Gezegen H., Guekht A., Yusof Khan A.H.K., Santacatterina M., Sejvar J., Thakur K.T., et al. Neurological Events Reported after COVID-19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System. Ann. Neurol. 2022;91:756&#x2013;771. doi: 10.1002/ana.26339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26339</ArticleId><ArticleId IdType="pmc">PMC9082459</ArticleId><ArticleId IdType="pubmed">35233819</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bermingham C., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., Alwan N.A., Walker A.S. Trajectory of Long Covid Symptoms after COVID-19 Vaccination: Community Based Cohort Study. BMJ. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwab C., Domke L.M., Hartmann L., Stenzinger A., Longerich T., Schirmacher P. Autopsy-Based Histopathological Characterization of Myocarditis after Anti-SARS-CoV-2-Vaccination. Clin. Res. Cardiol. 2023;112:431&#x2013;440. doi: 10.1007/s00392-022-02129-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-022-02129-5</ArticleId><ArticleId IdType="pmc">PMC9702955</ArticleId><ArticleId IdType="pubmed">36436002</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenblum H.G., Gee J., Liu R., Marquez P.L., Zhang B., Strid P., Abara W.E., McNeil M.M., Myers T.R., Hause A.M., et al. Safety of MRNA Vaccines Administered during the Initial 6 Months of the US COVID-19 Vaccination Programme: An Observational Study of Reports to the Vaccine Adverse Event Reporting System and v-Safe. Lancet Infect. Dis. 2022;22:802&#x2013;812. doi: 10.1016/S1473-3099(22)00054-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00054-8</ArticleId><ArticleId IdType="pmc">PMC8901181</ArticleId><ArticleId IdType="pubmed">35271805</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerman B.A., Madenci A.L., Gerlovin H., Kurgansky K.E., Wise J.K., Figueroa Mu&#xf1;iz M.J., Ferolito B.R., Gagnon D.R., Gaziano J.M., Cho K., et al. Comparative Safety of BNT162b2 and MRNA-1273 Vaccines in a Nationwide Cohort of US Veterans. JAMA Intern. Med. 2022;182:739&#x2013;746. doi: 10.1001/jamainternmed.2022.2109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2022.2109</ArticleId><ArticleId IdType="pmc">PMC9194743</ArticleId><ArticleId IdType="pubmed">35696161</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponti G., Pastorino L., Manfredini M., Ozben T., Oliva G., Kaleci S., Iannella R., Tomasi A. COVID-19 Spreading across World Correlates with C677T Allele of the Methylenetetrahydrofolate Reductase (MTHFR) Gene Prevalence. J. Clin. Lab. Anal. 2021;35:e23798. doi: 10.1002/jcla.23798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.23798</ArticleId><ArticleId IdType="pmc">PMC8209953</ArticleId><ArticleId IdType="pubmed">34061414</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpen&#xe8; G., Negrini D., Henry B.M., Montagnana M., Lippi G. Homocysteine in Coronavirus Disease (COVID-19): A Systematic Literature Review. Diagnosis. 2022;9:306&#x2013;310. doi: 10.1515/dx-2022-0042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/dx-2022-0042</ArticleId><ArticleId IdType="pubmed">35704707</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponti G., Roli L., Oliva G., Manfredini M., Trenti T., Kaleci S., Iannella R., Balzano B., Coppola A., Fiorentino G., et al. Homocysteine (Hcy) Assessment to Predict Outcomes of Hospitalized COVID-19 Patients: A Multicenter Study on 313 COVID-19 Patients. Clin. Chem. Lab. Med. 2021;59:e354&#x2013;e357. doi: 10.1515/cclm-2021-0168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2021-0168</ArticleId><ArticleId IdType="pubmed">33768762</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Farha M., Al-Sabah S., Hammad M.M., Hebbar P., Channanath A.M., John S.E., Taher I., Almaeen A., Ghazy A., Mohammad A., et al. Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism. Front Pharm. 2020;11:587451. doi: 10.3389/fphar.2020.587451.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.587451</ArticleId><ArticleId IdType="pmc">PMC7756688</ArticleId><ArticleId IdType="pubmed">33362545</ArticleId></ArticleIdList></Reference><Reference><Citation>Karst M., Hollenhorst J., Achenbach J. Life-Threatening Course in Coronavirus Disease 2019 (COVID-19): Is There a Link to Methylenetetrahydrofolic Acid Reductase (MTHFR) Polymorphism and Hyperhomocysteinemia? Med. Hypotheses. 2020;144:110234. doi: 10.1016/j.mehy.2020.110234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110234</ArticleId><ArticleId IdType="pmc">PMC7467063</ArticleId><ArticleId IdType="pubmed">33254541</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruce Yu Y., Taraban M.B., Briggs K.T. All Vials Are Not the Same: Potential Role of Vaccine Quality in Vaccine Adverse Reactions. Vaccine. 2021;39:6565&#x2013;6569. doi: 10.1016/j.vaccine.2021.09.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.09.065</ArticleId><ArticleId IdType="pmc">PMC8492451</ArticleId><ArticleId IdType="pubmed">34625289</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha N.K., Burke P.C., Nowacki A.S., Simon J.F., Hagen A., Gordon S.M. Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine. medRxiv. 2023 doi: 10.1093/ofid/ofad209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad209</ArticleId><ArticleId IdType="pmc">PMC10234376</ArticleId><ArticleId IdType="pubmed">37274183</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M.A., Wieler H.J., Enders P., Buchholz H.-G., Plachter B. Age- and Sex-Graded Data Evaluation of Vaccination Reactions after Initial Injection of the BNT162b2 MRNA Vaccine in a Local Vaccination Center in Germany. Vaccines. 2021;9:911. doi: 10.3390/vaccines9080911.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9080911</ArticleId><ArticleId IdType="pmc">PMC8402474</ArticleId><ArticleId IdType="pubmed">34452036</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaby P., Benn C.S., Flanagan K.L., Klein S.L., Kollmann T.R., Lynn D.J., Shann F. The Non-Specific and Sex-Differential Effects of Vaccines. Nat. Rev. Immunol. 2020;20:464&#x2013;470. doi: 10.1038/s41577-020-0338-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0338-x</ArticleId><ArticleId IdType="pmc">PMC7252419</ArticleId><ArticleId IdType="pubmed">32461674</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai A.P., Desai A.P., Loomis G.J. Relationship between Pre-Existing Allergies and Anaphylactic Reactions Post MRNA COVID-19 Vaccine Administration. Vaccine. 2021;39:4407&#x2013;4409. doi: 10.1016/j.vaccine.2021.06.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.06.058</ArticleId><ArticleId IdType="pmc">PMC8220987</ArticleId><ArticleId IdType="pubmed">34215453</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E.-J., Beltrami-Moreira M., Al-Samkari H., Cuker A., DiRaimo J., Gernsheimer T., Kruse A., Kessler C., Kruse C., Leavitt A.D., et al. SARS-CoV-2 Vaccination and ITP in Patients with de Novo or Preexisting ITP. Blood. 2022;139:1564&#x2013;1574. doi: 10.1182/blood.2021013411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021013411</ArticleId><ArticleId IdType="pmc">PMC8483984</ArticleId><ArticleId IdType="pubmed">34587251</ArticleId></ArticleIdList></Reference><Reference><Citation>Iddir M., Brito A., Dingeo G., Fernandez Del Campo S.S., Samouda H., La Frano M.R., Bohn T. Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis. Nutrients. 2020;12:1562. doi: 10.3390/nu12061562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12061562</ArticleId><ArticleId IdType="pmc">PMC7352291</ArticleId><ArticleId IdType="pubmed">32471251</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakeshbandi M., Maini R., Daniel P., Rosengarten S., Parmar P., Wilson C., Kim J.M., Oommen A., Mecklenburg M., Salvani J., et al. The Impact of Obesity on COVID-19 Complications: A Retrospective Cohort Study. Int. J. Obes. 2020;44:1832&#x2013;1837. doi: 10.1038/s41366-020-0648-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-020-0648-x</ArticleId><ArticleId IdType="pmc">PMC7382318</ArticleId><ArticleId IdType="pubmed">32712623</ArticleId></ArticleIdList></Reference><Reference><Citation>Apicella M., Campopiano M.C., Mantuano M., Mazoni L., Coppelli A., Del Prato S. COVID-19 in People with Diabetes: Understanding the Reasons for Worse Outcomes. Lancet Diabetes Endocrinol. 2020;8:782&#x2013;792. doi: 10.1016/S2213-8587(20)30238-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30238-2</ArticleId><ArticleId IdType="pmc">PMC7367664</ArticleId><ArticleId IdType="pubmed">32687793</ArticleId></ArticleIdList></Reference><Reference><Citation>Logette E., Lorin C., Favreau C., Oshurko E., Coggan J.S., Casalegno F., Sy M.F., Monney C., Bertschy M., Delattre E., et al. A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19. Front. Public Health. 2021;9:695139. doi: 10.3389/fpubh.2021.695139.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.695139</ArticleId><ArticleId IdType="pmc">PMC8356061</ArticleId><ArticleId IdType="pubmed">34395368</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt E.M., Steffen L.M., Moran A., Basu S., Steinberger J., Ross J.A., Hong C.-P., Sinaiko A.R. Fruit and Vegetable Consumption and Its Relation to Markers of Inflammation and Oxidative Stress in Adolescents. J. Am. Diet. Assoc. 2009;109:414&#x2013;421. doi: 10.1016/j.jada.2008.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jada.2008.11.036</ArticleId><ArticleId IdType="pmc">PMC2676354</ArticleId><ArticleId IdType="pubmed">19248856</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y.-C., Sheen J.-M., Hu W.L., Hung Y.-C. Polyphenols and Oxidative Stress in Atherosclerosis-Related Ischemic Heart Disease and Stroke. Oxidative Med. Cell. Longev. 2017;2017:8526438. doi: 10.1155/2017/8526438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/8526438</ArticleId><ArticleId IdType="pmc">PMC5727797</ArticleId><ArticleId IdType="pubmed">29317985</ArticleId></ArticleIdList></Reference><Reference><Citation>Serino A., Salazar G. Protective Role of Polyphenols against Vascular Inflammation, Aging and Cardiovascular Disease. Nutrients. 2018;11:53. doi: 10.3390/nu11010053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11010053</ArticleId><ArticleId IdType="pmc">PMC6357531</ArticleId><ArticleId IdType="pubmed">30597847</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkaid Y., Hand T.W. Role of the Microbiota in Immunity and Inflammation. Cell. 2014;157:121&#x2013;141. doi: 10.1016/j.cell.2014.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.03.011</ArticleId><ArticleId IdType="pmc">PMC4056765</ArticleId><ArticleId IdType="pubmed">24679531</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C.-Y., Zhang F., Liu Q., Li A.Y., Chung A.C., Cheung C.P., Tso E.Y., Fung K.S., et al. Gut Microbiota Composition Reflects Disease Severity and Dysfunctional Immune Responses in Patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Liu Q., Zhang F., Lui G., Tso E., Yeoh Y.K., Chen Z., Boon S., Chan F.K.L., Chan P., et al. Depicting SARS-CoV-2 Faecal Viral Activity in Association with Gut Microbiota Composition in Patients with COVID-19. Gut. 2021;70:276&#x2013;284. doi: 10.1136/gutjnl-2020-322294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-322294</ArticleId><ArticleId IdType="pmc">PMC7385744</ArticleId><ArticleId IdType="pubmed">32690600</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira C., Viana S.D., Reis F. Gut Microbiota Dysbiosis&#x2013;Immune Hyperresponse&#x2013;Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches. Microorganisms. 2020;8:1514. doi: 10.3390/microorganisms8101514.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8101514</ArticleId><ArticleId IdType="pmc">PMC7601735</ArticleId><ArticleId IdType="pubmed">33019592</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., van Haperen R., Guti&#xe9;rrez-&#xc1;lvarez J., Li W., Okba N.M.A., Albulescu I., Widjaja I., van Dieren B., Fernandez-Delgado R., Sola I., et al. A Conserved Immunogenic and Vulnerable Site on the Coronavirus Spike Protein Delineated by Cross-Reactive Monoclonal Antibodies. Nat. Commun. 2021;12:1715. doi: 10.1038/s41467-021-21968-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21968-w</ArticleId><ArticleId IdType="pmc">PMC7969777</ArticleId><ArticleId IdType="pubmed">33731724</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu. Rev. Virol. 2016;3:237&#x2013;261. doi: 10.1146/annurev-virology-110615-042301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-110615-042301</ArticleId><ArticleId IdType="pmc">PMC5457962</ArticleId><ArticleId IdType="pubmed">27578435</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard T.D. A Guide to Simple and Informative Binding Assays. Mol. Biol. Cell. 2010;21:4061&#x2013;4067. doi: 10.1091/mbc.e10-08-0683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e10-08-0683</ArticleId><ArticleId IdType="pmc">PMC2993736</ArticleId><ArticleId IdType="pubmed">21115850</ArticleId></ArticleIdList></Reference><Reference><Citation>Baer A., Kehn-Hall K. Viral Concentration Determination Through Plaque Assays: Using Traditional and Novel Overlay Systems. J. Vis. Exp. 2014:52065. doi: 10.3791/52065.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/52065</ArticleId><ArticleId IdType="pmc">PMC4255882</ArticleId><ArticleId IdType="pubmed">25407402</ArticleId></ArticleIdList></Reference><Reference><Citation>Puren A., Gerlach J.L., Weigl B.H., Kelso D.M., Domingo G.J. Laboratory Operations, Specimen Processing, and Handling for Viral Load Testing and Surveillance. J. Infect. Dis. 2010;201((Suppl. 1)):S27&#x2013;S36. doi: 10.1086/650390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/650390</ArticleId><ArticleId IdType="pubmed">20225943</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillette J.R. Problems in Correlating InVitro and InVivo Studies of Drug Metabolism. In: Benet L.Z., Levy G., Ferraiolo B.L., editors. Pharmacokinetics: A Modern View. Springer; Boston, MA, USA: 1984. pp. 235&#x2013;252.</Citation></Reference><Reference><Citation>Faraoni D., Schaefer S.T. Randomized Controlled Trials vs. Observational Studies: Why Not Just Live Together? BMC Anesth. 2016;16:102. doi: 10.1186/s12871-016-0265-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-016-0265-3</ArticleId><ArticleId IdType="pmc">PMC5073487</ArticleId><ArticleId IdType="pubmed">27769172</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam A., Bashir M.S., Joyce K., Rashid H., Laher I., Elshazly S. An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management Recommendations. Molecules. 2021;26:5004. doi: 10.3390/molecules26165004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26165004</ArticleId><ArticleId IdType="pmc">PMC8400504</ArticleId><ArticleId IdType="pubmed">34443589</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas G., Couture F., Kwiatkowska A. The Path to Therapeutic Furin Inhibitors: From Yeast Pheromones to SARS-CoV-2. Int. J. Mol. Sci. 2022;23:3435. doi: 10.3390/ijms23073435.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23073435</ArticleId><ArticleId IdType="pmc">PMC8999023</ArticleId><ArticleId IdType="pubmed">35408793</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y.-W., Chao T.-L., Li C.-L., Chiu M.-F., Kao H.-C., Wang S.-H., Pang Y.-H., Lin C.-H., Tsai Y.-M., Lee W.-H., et al. Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects. Cell Rep. 2020;33:108254. doi: 10.1016/j.celrep.2020.108254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108254</ArticleId><ArticleId IdType="pmc">PMC7510585</ArticleId><ArticleId IdType="pubmed">33007239</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C., Zheng M., Yang Y., Gu X., Yang K., Li M., Liu Y., Zhang Q., Zhang P., Wang Y., et al. Furin: A Potential Therapeutic Target for COVID-19. iScience. 2020;23:101642. doi: 10.1016/j.isci.2020.101642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101642</ArticleId><ArticleId IdType="pmc">PMC7534598</ArticleId><ArticleId IdType="pubmed">33043282</ArticleId></ArticleIdList></Reference><Reference><Citation>Mykytyn A.Z., Breugem T.I., Riesebosch S., Schipper D., van den Doel P.B., Rottier R.J., Lamers M.M., Haagmans B.L. SARS-CoV-2 Entry into Human Airway Organoids Is Serine Protease-Mediated and Facilitated by the Multibasic Cleavage Site. eLife. 2021;10:e64508. doi: 10.7554/eLife.64508.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.64508</ArticleId><ArticleId IdType="pmc">PMC7806259</ArticleId><ArticleId IdType="pubmed">33393462</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosendal E., Mihai I.S., Becker M., Das D., Fr&#xe4;ngsmyr L., Persson B.D., Rankin G.D., Gr&#xf6;ning R., Trygg J., Forsell M., et al. Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections. mBio. 2022;13:e0089222. doi: 10.1128/mbio.00892-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00892-22</ArticleId><ArticleId IdType="pmc">PMC9239148</ArticleId><ArticleId IdType="pubmed">35532162</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulla A., Heald-Sargent T., Subramanya G., Zhao J., Perlman S., Gallagher T. A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry. J. Virol. 2011;85:873&#x2013;882. doi: 10.1128/JVI.02062-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02062-10</ArticleId><ArticleId IdType="pmc">PMC3020023</ArticleId><ArticleId IdType="pubmed">21068237</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Hou Y., Ge S., Wang X., Wang J., Hu T., Lv Y., He H., Wang C. Screened Antipsychotic Drugs Inhibit SARS-CoV-2 Binding with ACE2 in Vitro. Life Sci. 2021;266:118889. doi: 10.1016/j.lfs.2020.118889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118889</ArticleId><ArticleId IdType="pmc">PMC7834886</ArticleId><ArticleId IdType="pubmed">33310043</ArticleId></ArticleIdList></Reference><Reference><Citation>Su S., Chen J., Wang Y., Wong L.M., Zhu Z., Jiang G., Liu P. Lenalidomide Downregulates ACE2 Protein Abundance to Alleviate Infection by SARS-CoV-2 Spike Protein Conditioned Pseudoviruses. Signal Transduct. Target. Ther. 2021;6:186. doi: 10.1038/s41392-021-00608-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00608-1</ArticleId><ArticleId IdType="pmc">PMC8107201</ArticleId><ArticleId IdType="pubmed">33972500</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadan A.A., Mayilsamy K., McGill A.R., Ghosh A., Giulianotti M.A., Donow H.M., Mohapatra S.S., Mohapatra S., Chandran B., Deschenes R.J., et al. Inhibition of SARS-CoV-2 Spike Protein Palmitoylation Reduces Virus Infectivity. bioRxiv. 2021 doi: 10.1101/2021.10.07.463402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.07.463402</ArticleId><ArticleId IdType="pmc">PMC8950683</ArticleId><ArticleId IdType="pubmed">35336938</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpoot S., Ohishi T., Kumar A., Pan Q., Banerjee S., Zhang K.Y.J., Baig M.S. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor. Drugs R&amp;D. 2021;21:273&#x2013;283. doi: 10.1007/s40268-021-00357-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40268-021-00357-0</ArticleId><ArticleId IdType="pmc">PMC8319882</ArticleId><ArticleId IdType="pubmed">34324175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruse K.B., Brodsky J.L., McCracken A.A. Autophagy: An ER Protein Quality Control Process. Autophagy. 2006;2:135&#x2013;137. doi: 10.4161/auto.2.2.2388.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.2.2.2388</ArticleId><ArticleId IdType="pubmed">16874086</ArticleId></ArticleIdList></Reference><Reference><Citation>De R., Dutta S. Role of the Microbiome in the Pathogenesis of COVID-19. Front. Cell Infect. Microbiol. 2022;12:736397. doi: 10.3389/fcimb.2022.736397.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.736397</ArticleId><ArticleId IdType="pmc">PMC9009446</ArticleId><ArticleId IdType="pubmed">35433495</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan R.K., Kashour T., Hamid Q., Halwani R., Tleyjeh I.M. Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19. Front. Immunol. 2021;12:686029. doi: 10.3389/fimmu.2021.686029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686029</ArticleId><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran J.P., Bradley E., Zeamer A.L., Cincotta L., Salive M.-C., Dutta P., Mutaawe S., Anya O., Meza-Segura M., Moormann A.M., et al. Inflammation-Type Dysbiosis of the Oral Microbiome Associates with the Duration of COVID-19 Symptoms and Long COVID. JCI Insight. 2021;6:e152346. doi: 10.1172/jci.insight.152346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.152346</ArticleId><ArticleId IdType="pmc">PMC8564890</ArticleId><ArticleId IdType="pubmed">34403368</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-Acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazan S., Stollman N., Bozkurt H.S., Dave S., Papoutsis A.J., Daniels J., Barrows B.D., Quigley E.M., Borody T.J. Lost Microbes of COVID-19: Bifidobacterium, Faecalibacterium Depletion and Decreased Microbiome Diversity Associated with SARS-CoV-2 Infection Severity. BMJ Open Gastroenterol. 2022;9:e000871. doi: 10.1136/bmjgast-2022-000871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgast-2022-000871</ArticleId><ArticleId IdType="pmc">PMC9051551</ArticleId><ArticleId IdType="pubmed">35483736</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez-Castrell&#xf3;n P., Gandara-Mart&#xed; T., Abreu Y Abreu A.T., Nieto-Rufino C.D., L&#xf3;pez-Ordu&#xf1;a E., Jim&#xe9;nez-Escobar I., Jim&#xe9;nez-Guti&#xe9;rrez C., L&#xf3;pez-Velazquez G., Espadaler-Mazo J. Probiotic Improves Symptomatic and Viral Clearance in Covid19 Outpatients: A Randomized, Quadruple-Blinded, Placebo-Controlled Trial. Gut Microbes. 2022;14:2018899. doi: 10.1080/19490976.2021.2018899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.2018899</ArticleId><ArticleId IdType="pmc">PMC8757475</ArticleId><ArticleId IdType="pubmed">35014600</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Gu S., Chen Y., Lu H., Shi D., Guo J., Wu W.-R., Yang Y., Li Y., Xu K.-J., et al. Six-Month Follow-up of Gut Microbiota Richness in Patients with COVID-19. Gut. 2022;71:222&#x2013;225. doi: 10.1136/gutjnl-2021-324090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324090</ArticleId><ArticleId IdType="pmc">PMC8666823</ArticleId><ArticleId IdType="pubmed">33833065</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Wu X., Wen W., Lan P. Gut Microbiome Alterations in COVID-19. Genom. Proteom. Bioinform. 2021;19:679&#x2013;688. doi: 10.1016/j.gpb.2021.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gpb.2021.09.004</ArticleId><ArticleId IdType="pmc">PMC8478109</ArticleId><ArticleId IdType="pubmed">34560321</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibino S., Hayashida K. Modifiable Host Factors for the Prevention and Treatment of COVID-19: Diet and Lifestyle/Diet and Lifestyle Factors in the Prevention of COVID-19. Nutrients. 2022;14:1876. doi: 10.3390/nu14091876.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14091876</ArticleId><ArticleId IdType="pmc">PMC9102954</ArticleId><ArticleId IdType="pubmed">35565841</ArticleId></ArticleIdList></Reference><Reference><Citation>Losso J.N., Losso M.N., Toc M., Inungu J.N., Finley J.W. The Young Age and Plant-Based Diet Hypothesis for Low SARS-CoV-2 Infection and COVID-19 Pandemic in Sub-Saharan Africa. Plant Foods Hum. Nutr. 2021;76:270&#x2013;280. doi: 10.1007/s11130-021-00907-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11130-021-00907-6</ArticleId><ArticleId IdType="pmc">PMC8225309</ArticleId><ArticleId IdType="pubmed">34169470</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.B. Low Dietary Sodium Potentially Mediates COVID-19 Prevention Associated with Whole-Food Plant-Based Diets. Br. J. Nutr. 2022;129:1136&#x2013;1141. doi: 10.1017/S0007114522002252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114522002252</ArticleId><ArticleId IdType="pmc">PMC10011594</ArticleId><ArticleId IdType="pubmed">35912674</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H., Rebholz C.M., Hegde S., LaFiura C., Raghavan M., Lloyd J.F., Cheng S., Seidelmann S.B. Plant-Based Diets, Pescatarian Diets and COVID-19 Severity: A Population-Based Case&#x2013;Control Study in Six Countries. BMJ Nutr. Prev. Health. 2021;4:257&#x2013;266. doi: 10.1136/bmjnph-2021-000272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjnph-2021-000272</ArticleId><ArticleId IdType="pmc">PMC8219480</ArticleId><ArticleId IdType="pubmed">34308134</ArticleId></ArticleIdList></Reference><Reference><Citation>Benton D., Williams C., Brown A. Impact of Consuming a Milk Drink Containing a Probiotic on Mood and Cognition. Eur. J. Clin. Nutr. 2007;61:355&#x2013;361. doi: 10.1038/sj.ejcn.1602546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ejcn.1602546</ArticleId><ArticleId IdType="pubmed">17151594</ArticleId></ArticleIdList></Reference><Reference><Citation>de Falco B., Amato M., Lanzotti V. Chia Seeds Products: An Overview. Phytochem. Rev. 2017;16:745&#x2013;760. doi: 10.1007/s11101-017-9511-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11101-017-9511-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Y.-H., Xu Y., Song F., Wang Z.-M., Li Y.-H., Zhao M., He F., Tian Z., Yang Y. Protective Effects of Konjac Glucomannan on Gut Microbiome with Antibiotic Perturbation in Mice. Carbohydr. Polym. 2022;290:119476. doi: 10.1016/j.carbpol.2022.119476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carbpol.2022.119476</ArticleId><ArticleId IdType="pubmed">35550768</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Zhao Y., Yang W., Song G., Zhong P., Ren Y., Zhong G. Structural Complexity of Konjac Glucomannan and Its Derivatives Governs the Diversity and Outputs of Gut Microbiota. Carbohydr. Polym. 2022;292:119639. doi: 10.1016/j.carbpol.2022.119639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carbpol.2022.119639</ArticleId><ArticleId IdType="pubmed">35725199</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas R., Aldous J., Forsyth R., Chater A., Williams M. The Influence of a Blend of Probiotic Lactobacillus and Prebiotic Inulin on the Duration and Severity of Symptoms among Individuals with COVID-19. Infect. Dis. Diagn. Treat. 2021;5:1&#x2013;12.</Citation></Reference><Reference><Citation>Wastyk H.C., Fragiadakis G.K., Perelman D., Dahan D., Merrill B.D., Yu F.B., Topf M., Gonzalez C.G., Treuren W.V., Han S., et al. Gut-Microbiota-Targeted Diets Modulate Human Immune Status. Cell. 2021;184:4137&#x2013;4153.e14. doi: 10.1016/j.cell.2021.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.06.019</ArticleId><ArticleId IdType="pmc">PMC9020749</ArticleId><ArticleId IdType="pubmed">34256014</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi G.A., Sacco O., Mancino E., Cristiani L., Midulla F. Differences and Similarities between SARS-CoV and SARS-CoV-2: Spike Receptor-Binding Domain Recognition and Host Cell Infection with Support of Cellular Serine Proteases. Infection. 2020;48:665&#x2013;669. doi: 10.1007/s15010-020-01486-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01486-5</ArticleId><ArticleId IdType="pmc">PMC7393809</ArticleId><ArticleId IdType="pubmed">32737833</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen E., Koopmans M., Go U., Hamer D.H., Petrosillo N., Castelli F., Storgaard M., Khalili S.A., Simonsen L. Comparing SARS-CoV-2 with SARS-CoV and Influenza Pandemics. Lancet Infect. Dis. 2020;20:e238&#x2013;e244. doi: 10.1016/S1473-3099(20)30484-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30484-9</ArticleId><ArticleId IdType="pmc">PMC7333991</ArticleId><ArticleId IdType="pubmed">32628905</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., P&#xf6;hlmann S. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. Mol. Cell. 2020;78:779&#x2013;784.e5. doi: 10.1016/j.molcel.2020.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.04.022</ArticleId><ArticleId IdType="pmc">PMC7194065</ArticleId><ArticleId IdType="pubmed">32362314</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutard B., Valle C., de Lamballerie X., Canard B., Seidah N.G., Decroly E. The Spike Glycoprotein of the New Coronavirus 2019-NCoV Contains a Furin-like Cleavage Site Absent in CoV of the Same Clade. Antivir. Res. 2020;176:104742. doi: 10.1016/j.antiviral.2020.104742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2020.104742</ArticleId><ArticleId IdType="pmc">PMC7114094</ArticleId><ArticleId IdType="pubmed">32057769</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.-H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen T., Titze U., Kulamadayil-Heidenreich N.S.A., Glombitza S., Tebbe J.J., R&#xf6;cken C., Schulz B., Weise M., Wilkens L. First Case of Postmortem Study in a Patient Vaccinated against SARS-CoV-2. Int. J. Infect. Dis. 2021;107:172&#x2013;175. doi: 10.1016/j.ijid.2021.04.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.04.053</ArticleId><ArticleId IdType="pmc">PMC8051011</ArticleId><ArticleId IdType="pubmed">33872783</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J.L., P&#xe9;rez Marc G., Moreira E.D., Zerbini C., et al. Safety and Efficacy of the BNT162b2 MRNA COVID-19 Vaccine. N. Engl. J. Med. 2020;383:2603&#x2013;2615. doi: 10.1056/NEJMoa2034577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034577</ArticleId><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbett K.S., Flynn B., Foulds K.E., Francica J.R., Boyoglu-Barnum S., Werner A.P., Flach B., O&#x2019;Connell S., Bock K.W., Minai M., et al. Evaluation of the MRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates. N. Engl. J. Med. 2020;383:1544&#x2013;1555. doi: 10.1056/NEJMoa2024671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2024671</ArticleId><ArticleId IdType="pmc">PMC7449230</ArticleId><ArticleId IdType="pubmed">32722908</ArticleId></ArticleIdList></Reference><Reference><Citation>Bos R., Rutten L., van der Lubbe J.E.M., Bakkers M.J.G., Hardenberg G., Wegmann F., Zuijdgeest D., de Wilde A.H., Koornneef A., Verwilligen A., et al. Ad26 Vector-Based COVID-19 Vaccine Encoding a Prefusion-Stabilized SARS-CoV-2 Spike Immunogen Induces Potent Humoral and Cellular Immune Responses. Npj Vaccines. 2020;5:91. doi: 10.1038/s41541-020-00243-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-020-00243-x</ArticleId><ArticleId IdType="pmc">PMC7522255</ArticleId><ArticleId IdType="pubmed">33083026</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangaru S., Ozorowski G., Turner H.L., Antanasijevic A., Huang D., Wang X., Torres J.L., Diedrich J.K., Tian J.-H., Portnoff A.D., et al. Structural Analysis of Full-Length SARS-CoV-2 Spike Protein from an Advanced Vaccine Candidate. Science. 2020;370:1089&#x2013;1094. doi: 10.1126/science.abe1502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe1502</ArticleId><ArticleId IdType="pmc">PMC7857404</ArticleId><ArticleId IdType="pubmed">33082295</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallesen J., Wang N., Corbett K.S., Wrapp D., Kirchdoerfer R.N., Turner H.L., Cottrell C.A., Becker M.M., Wang L., Shi W., et al. Immunogenicity and Structures of a Rationally Designed Prefusion MERS-CoV Spike Antigen. Proc. Natl. Acad. Sci. USA. 2017;114:E7348&#x2013;E7357. doi: 10.1073/pnas.1707304114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1707304114</ArticleId><ArticleId IdType="pmc">PMC5584442</ArticleId><ArticleId IdType="pubmed">28807998</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y., Mendon&#xe7;a L., Allen E.R., Howe A., Lee M., Allen J.D., Chawla H., Pulido D., Donnellan F., Davies H., et al. Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 NCoV-19/AZD1222 Vaccine. ACS Cent. Sci. 2021;7:594&#x2013;602. doi: 10.1021/acscentsci.1c00080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscentsci.1c00080</ArticleId><ArticleId IdType="pmc">PMC8043200</ArticleId><ArticleId IdType="pubmed">34056089</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Q., Bao L., Mao H., Wang L., Xu K., Yang M., Li Y., Zhu L., Wang N., Lv Z., et al. Development of an Inactivated Vaccine Candidate for SARS-CoV-2. Science. 2020;369:77&#x2013;81. doi: 10.1126/science.abc1932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc1932</ArticleId><ArticleId IdType="pmc">PMC7202686</ArticleId><ArticleId IdType="pubmed">32376603</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu M., Chamblee M., Zhang Y., Ye C., Dravid P., Park J.-G., Mahesh K., Trivedi S., Murthy S., Sharma H., et al. SARS-CoV-2 Prefusion Spike Protein Stabilized by Six Rather than Two Prolines Is More Potent for Inducing Antibodies That Neutralize Viral Variants of Concern. Proc. Natl. Acad. Sci. USA. 2022;119:e2110105119. doi: 10.1073/pnas.2110105119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2110105119</ArticleId><ArticleId IdType="pmc">PMC9436349</ArticleId><ArticleId IdType="pubmed">35994646</ArticleId></ArticleIdList></Reference><Reference><Citation>Amanat F., Strohmeier S., Rathnasinghe R., Schotsaert M., Coughlan L., Garc&#xed;a-Sastre A., Krammer F. Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model. mBio. 2021;12:e02648-20. doi: 10.1128/mBio.02648-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02648-20</ArticleId><ArticleId IdType="pmc">PMC8092267</ArticleId><ArticleId IdType="pubmed">33653892</ArticleId></ArticleIdList></Reference><Reference><Citation>Murza A., Dion S.P., Boudreault P.-L., D&#xe9;silets A., Leduc R., Marsault &#xc9;. Inhibitors of Type II Transmembrane Serine Proteases in the Treatment of Diseases of the Respiratory Tract&#x2014;A Review of Patent Literature. Expert. Opin. Pat. 2020;30:807&#x2013;824. doi: 10.1080/13543776.2020.1817390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13543776.2020.1817390</ArticleId><ArticleId IdType="pubmed">32887532</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman N., Basharat Z., Yousuf M., Castaldo G., Rastrelli L., Khan H. Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2) Molecules. 2020;25:2271. doi: 10.3390/molecules25102271.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25102271</ArticleId><ArticleId IdType="pmc">PMC7287752</ArticleId><ArticleId IdType="pubmed">32408547</ArticleId></ArticleIdList></Reference><Reference><Citation>Azouz N.P., Klingler A.M., Callahan V., Akhrymuk I.V., Elez K., Raich L., Henry B.M., Benoit J.L., Benoit S.W., No&#xe9; F., et al. Alpha 1 Antitrypsin Is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2. Pathog. Immun. 2021;6:55&#x2013;74. doi: 10.20411/pai.v6i1.408.</Citation><ArticleIdList><ArticleId IdType="doi">10.20411/pai.v6i1.408</ArticleId><ArticleId IdType="pmc">PMC8097828</ArticleId><ArticleId IdType="pubmed">33969249</ArticleId></ArticleIdList></Reference><Reference><Citation>Longo V.D., Mattson M.P. Fasting: Molecular Mechanisms and Clinical Applications. Cell Metab. 2014;19:181&#x2013;192. doi: 10.1016/j.cmet.2013.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2013.12.008</ArticleId><ArticleId IdType="pmc">PMC3946160</ArticleId><ArticleId IdType="pubmed">24440038</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagherniya M., Butler A.E., Barreto G.E., Sahebkar A. The Effect of Fasting or Calorie Restriction on Autophagy Induction: A Review of the Literature. Ageing Res. Rev. 2018;47:183&#x2013;197. doi: 10.1016/j.arr.2018.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2018.08.004</ArticleId><ArticleId IdType="pubmed">30172870</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandhorst S., Longo V.D. Protein Quantity and Source, Fasting-Mimicking Diets, and Longevity. Adv. Nutr. 2019;10:S340&#x2013;S350. doi: 10.1093/advances/nmz079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmz079</ArticleId><ArticleId IdType="pmc">PMC6855936</ArticleId><ArticleId IdType="pubmed">31728501</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuvayeva G., Bobak Y., Igumentseva N., Titone R., Morani F., Stasyk O., Isidoro C. Single Amino Acid Arginine Deprivation Triggers Prosurvival Autophagic Response in Ovarian Carcinoma SKOV3. Biomed. Res. Int. 2014;2014:505041. doi: 10.1155/2014/505041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/505041</ArticleId><ArticleId IdType="pmc">PMC4058691</ArticleId><ArticleId IdType="pubmed">24987688</ArticleId></ArticleIdList></Reference><Reference><Citation>Horne B.D., May H.T., Muhlestein J.B., Le V.T., Bair T.L., Knowlton K.U., Anderson J.L. Association of Periodic Fasting with Lower Severity of COVID-19 Outcomes in the SARS-CoV-2 Prevaccine Era: An Observational Cohort from the INSPIRE Registry. BMJ Nutr. Prev. Health. 2022;5:145&#x2013;153. doi: 10.1136/bmjnph-2022-000462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjnph-2022-000462</ArticleId><ArticleId IdType="pmc">PMC9813631</ArticleId><ArticleId IdType="pubmed">36619318</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura K., Shiina R., Kashiwagi K., Igarashi K. Decrease in Polyamines with Aging and Their Ingestion from Food and Drink. J. Biochem. 2006;139:81&#x2013;90. doi: 10.1093/jb/mvj003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jb/mvj003</ArticleId><ArticleId IdType="pubmed">16428322</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenberg T., Knauer H., Schauer A., B&#xfc;ttner S., Ruckenstuhl C., Carmona-Gutierrez D., Ring J., Schroeder S., Magnes C., Antonacci L., et al. Induction of Autophagy by Spermidine Promotes Longevity. Nat. Cell Biol. 2009;11:1305&#x2013;1314. doi: 10.1038/ncb1975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1975</ArticleId><ArticleId IdType="pubmed">19801973</ArticleId></ArticleIdList></Reference><Reference><Citation>Summers C.M., Valentine R.J. Acute Heat Exposure Alters Autophagy Signaling in C2C12 Myotubes. Front. Physiol. 2020;10:1521. doi: 10.3389/fphys.2019.01521.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2019.01521</ArticleId><ArticleId IdType="pmc">PMC6960406</ArticleId><ArticleId IdType="pubmed">31969827</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormick J.J., Dokladny K., Moseley P.L., Kenny G.P. Autophagy and Heat: A Potential Role for Heat Therapy to Improve Autophagic Function in Health and Disease. J. Appl. Physiol. 2021;130:1&#x2013;9. doi: 10.1152/japplphysiol.00542.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00542.2020</ArticleId><ArticleId IdType="pubmed">33119472</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Arcy M.S. A Review of Biologically Active Flavonoids as Inducers of Autophagy and Apoptosis in Neoplastic Cells and as Cytoprotective Agents in Non-Neoplastic Cells. Cell Biol. Int. 2022;46:1179&#x2013;1195. doi: 10.1002/cbin.11813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbin.11813</ArticleId><ArticleId IdType="pubmed">35544782</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasima N., Ozpolat B. Regulation of Autophagy by Polyphenolic Compounds as a Potential Therapeutic Strategy for Cancer. Cell Death Dis. 2014;5:e1509. doi: 10.1038/cddis.2014.467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.467</ArticleId><ArticleId IdType="pmc">PMC4260725</ArticleId><ArticleId IdType="pubmed">25375374</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S.-R., Fu Y.-S., Tsai M.-J., Cheng H., Weng C.-F. Natural Compounds from Herbs That Can Potentially Execute as Autophagy Inducers for Cancer Therapy. Int. J. Mol. Sci. 2017;18:1412. doi: 10.3390/ijms18071412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18071412</ArticleId><ArticleId IdType="pmc">PMC5535904</ArticleId><ArticleId IdType="pubmed">28671583</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrocola F., Malik S.A., Mari&#xf1;o G., Vacchelli E., Senovilla L., Chaba K., Niso-Santano M., Maiuri M.C., Madeo F., Kroemer G. Coffee Induces Autophagy in Vivo. Cell Cycle. 2014;13:1987&#x2013;1994. doi: 10.4161/cc.28929.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.28929</ArticleId><ArticleId IdType="pmc">PMC4111762</ArticleId><ArticleId IdType="pubmed">24769862</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraresi A., Titone R., Follo C., Castiglioni A., Chiorino G., Dhanasekaran D.N., Isidoro C. The Protein Restriction Mimetic Resveratrol Is an Autophagy Inducer Stronger than Amino Acid Starvation in Ovarian Cancer Cells. Mol. Carcinog. 2017;56:2681&#x2013;2691. doi: 10.1002/mc.22711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mc.22711</ArticleId><ArticleId IdType="pubmed">28856729</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu G., Wu Z., Shang J., Xie Z., Chen C., Zhang C. The Effects of Metformin on Autophagy. Biomed. Pharmacother. 2021;137:111286. doi: 10.1016/j.biopha.2021.111286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111286</ArticleId><ArticleId IdType="pubmed">33524789</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J., Nie J., Chen Z., Wang X., Hu H., Xu J., Lu J., Ma L., Ji H., Yuan J., et al. Cold Exposure-Induced Endoplasmic Reticulum Stress Regulates Autophagy through the SIRT2/FoxO1 Signaling Pathway. J. Cell. Physiol. 2022;237:3960&#x2013;3970. doi: 10.1002/jcp.30856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.30856</ArticleId><ArticleId IdType="pubmed">35938526</ArticleId></ArticleIdList></Reference><Reference><Citation>Yau W.W., Wong K.A., Zhou J., Thimmukonda N.K., Wu Y., Bay B.-H., Singh B.K., Yen P.M. Chronic Cold Exposure Induces Autophagy to Promote Fatty Acid Oxidation, Mitochondrial Turnover, and Thermogenesis in Brown Adipose Tissue. iScience. 2021;24:102434. doi: 10.1016/j.isci.2021.102434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102434</ArticleId><ArticleId IdType="pmc">PMC8134067</ArticleId><ArticleId IdType="pubmed">34027318</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.-C., Zhang S., Du T.-Y., Wang B., Sun X.-Q. Hyperbaric Oxygen Preconditioning Reduces Ischemia&#x2013;Reperfusion Injury by Stimulating Autophagy in Neurocyte. Brain Res. 2010;1323:149&#x2013;151. doi: 10.1016/j.brainres.2010.01.074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2010.01.074</ArticleId><ArticleId IdType="pubmed">20123088</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun P., Xu W., Zhao X., Zhang C., Lin X., Gong M., Fu Z. Ozone Induces Autophagy by Activating PPAR&#x3b3;/MTOR in Rat Chondrocytes Treated with IL-1&#x3b2;. J. Orthop. Surg. Res. 2022;17:351. doi: 10.1186/s13018-022-03233-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-022-03233-y</ArticleId><ArticleId IdType="pmc">PMC9287877</ArticleId><ArticleId IdType="pubmed">35842709</ArticleId></ArticleIdList></Reference><Reference><Citation>Mojtabavi H., Saghazadeh A., Rezaei N. Interleukin-6 and Severe COVID-19: A Systematic Review and Meta-Analysis. Eur. Cytokine Netw. 2020;31:44&#x2013;49. doi: 10.1684/ecn.2020.0448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1684/ecn.2020.0448</ArticleId><ArticleId IdType="pmc">PMC7530350</ArticleId><ArticleId IdType="pubmed">32933891</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Laubscher G.J., Pretorius E. A Central Role for Amyloid Fibrin Microclots in Long COVID/PASC: Origins and Therapeutic Implications. Biochem. J. 2022;479:537&#x2013;559. doi: 10.1042/BCJ20220016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent Clotting Protein Pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) Is Accompanied by Increased Levels of Antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Kotze M.J., Oladejo S.O., Watson L.R., Rajaratnam K., Watson B.W., Kell D.B. Prevalence of Symptoms, Comorbidities, Fibrin Amyloid Microclots and Platelet Pathology in Individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) Cardiovasc. Diabetol. 2022;21:148. doi: 10.1186/s12933-022-01579-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J.C., Hawley H.B. Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina. 2021;57:1163. doi: 10.3390/medicina57111163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57111163</ArticleId><ArticleId IdType="pmc">PMC8621006</ArticleId><ArticleId IdType="pubmed">34833382</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainous A.G., Rooks B.J., Orlando F.A. The Impact of Initial COVID-19 Episode Inflammation Among Adults on Mortality Within 12 Months Post-Hospital Discharge. Front. Med. 2022;9:891375. doi: 10.3389/fmed.2022.891375.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.891375</ArticleId><ArticleId IdType="pmc">PMC9135460</ArticleId><ArticleId IdType="pubmed">35646997</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayd&#x131;ny&#x131;lmaz F., Aksakal E., Pamukcu H.E., Aydemir S., Do&#x11f;an R., Sara&#xe7; &#x130;., Ayd&#x131;n S.&#x15e;., Kalkan K., G&#xfc;lc&#xfc; O., Tanbo&#x11f;a &#x130;.H. Significance of MPV, RDW and PDW with the Severity and Mortality of COVID-19 and Effects of Acetylsalicylic Acid Use. Clin. Appl. Thromb. Hemost. 2021;27:10760296211048808. doi: 10.1177/10760296211048808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10760296211048808</ArticleId><ArticleId IdType="pmc">PMC8558606</ArticleId><ArticleId IdType="pubmed">34713729</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianconi V., Violi F., Fallarino F., Pignatelli P., Sahebkar A., Pirro M. Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? Drugs. 2020;80:1383&#x2013;1396. doi: 10.1007/s40265-020-01365-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-020-01365-1</ArticleId><ArticleId IdType="pmc">PMC7376326</ArticleId><ArticleId IdType="pubmed">32705604</ArticleId></ArticleIdList></Reference><Reference><Citation>Clissold S.P. Aspirin and Related Derivatives of Salicylic Acid. Drugs. 1986;32:8&#x2013;26. doi: 10.2165/00003495-198600324-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00003495-198600324-00003</ArticleId><ArticleId IdType="pubmed">3552588</ArticleId></ArticleIdList></Reference><Reference><Citation>Storstein O., Nitter-Hauge S., Enge I. Thromboembolic Complications in Coronary Angiography: Prevention with Acetyl-Salicylic Acid. Acta Radiol. Diagn. 1977;18:555&#x2013;560. doi: 10.1177/028418517701800508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/028418517701800508</ArticleId><ArticleId IdType="pubmed">930630</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;sterud B., Brox J.H. The Clotting Time of Whole Blood in Plastic Tubes: The Influence of Exercise, Prostacyclin and Acetylsalicylic Acid. Thromb. Res. 1983;29:425&#x2013;435. doi: 10.1016/0049-3848(83)90246-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0049-3848(83)90246-3</ArticleId><ArticleId IdType="pubmed">6344315</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita M., Nomura K., Hong K., Ito Y., Asada A., Nishimuro S. Purification and Characterization of a Strong Fibrinolytic Enzyme (Nattokinase) in the Vegetable Cheese Natto, a Popular Soybean Fermented Food in Japan. Biochem. Biophys. Res. Commun. 1993;197:1340&#x2013;1347. doi: 10.1006/bbrc.1993.2624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1993.2624</ArticleId><ArticleId IdType="pubmed">8280151</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu R.-L., Lee K.-T., Wang J.-H., Lee L.Y.-L., Chen R.P.-Y. Amyloid-Degrading Ability of Nattokinase from Bacillus Subtilis Natto. J. Agric. Food Chem. 2009;57:503&#x2013;508. doi: 10.1021/jf803072r.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf803072r</ArticleId><ArticleId IdType="pubmed">19117402</ArticleId></ArticleIdList></Reference><Reference><Citation>Oba M., Rongduo W., Saito A., Okabayashi T., Yokota T., Yasuoka J., Sato Y., Nishifuji K., Wake H., Nibu Y., et al. Natto Extract, a Japanese Fermented Soybean Food, Directly Inhibits Viral Infections Including SARS-CoV-2 in Vitro. Biochem. Biophys. Res. Commun. 2021;570:21&#x2013;25. doi: 10.1016/j.bbrc.2021.07.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.07.034</ArticleId><ArticleId IdType="pmc">PMC8276596</ArticleId><ArticleId IdType="pubmed">34271432</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanikawa T., Kiba Y., Yu J., Hsu K., Chen S., Ishii A., Yokogawa T., Suzuki R., Inoue Y., Kitamura M. Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2. Molecules. 2022;27:5405. doi: 10.3390/molecules27175405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27175405</ArticleId><ArticleId IdType="pmc">PMC9458005</ArticleId><ArticleId IdType="pubmed">36080170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurosawa Y., Nirengi S., Homma T., Esaki K., Ohta M., Clark J.F., Hamaoka T. A Single-Dose of Oral Nattokinase Potentiates Thrombolysis and Anti-Coagulation Profiles. Sci. Rep. 2015;5:11601. doi: 10.1038/srep11601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep11601</ArticleId><ArticleId IdType="pmc">PMC4479826</ArticleId><ArticleId IdType="pubmed">26109079</ArticleId></ArticleIdList></Reference><Reference><Citation>Behera P., Patro B.K., Singh A.K., Chandanshive P.D., Ravikumar S.R., Pradhan S.K., Pentapati S.S.K., Batmanabane G., Mohapatra P.R., Padhy B.M., et al. Role of Ivermectin in the Prevention of SARS-CoV-2 Infection among Healthcare Workers in India: A Matched Case-Control Study. PLoS ONE. 2021;16:e0247163. doi: 10.1371/journal.pone.0247163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247163</ArticleId><ArticleId IdType="pmc">PMC7886121</ArticleId><ArticleId IdType="pubmed">33592050</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaidi A.K., Dehgani-Mobaraki P. The Mechanisms of Action of Ivermectin against SARS-CoV-2&#x2014;An Extensive Review. J. Antibiot. 2022;75:60&#x2013;71. doi: 10.1038/s41429-021-00491-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41429-021-00491-6</ArticleId><ArticleId IdType="pmc">PMC8688140</ArticleId><ArticleId IdType="pubmed">34931048</ArticleId></ArticleIdList></Reference><Reference><Citation>Caly L., Druce J.D., Catton M.G., Jans D.A., Wagstaff K.M. The FDA-Approved Drug Ivermectin Inhibits the Replication of SARS-CoV-2 in Vitro. Antivir. Res. 2020;178:104787. doi: 10.1016/j.antiviral.2020.104787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2020.104787</ArticleId><ArticleId IdType="pmc">PMC7129059</ArticleId><ArticleId IdType="pubmed">32251768</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryant A., Lawrie T.A., Dowswell T., Fordham E.J., Mitchell S., Hill S.R., Tham T.C. Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. Am. J. Ther. 2021;28:e434&#x2013;e460. doi: 10.1097/MJT.0000000000001402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MJT.0000000000001402</ArticleId><ArticleId IdType="pmc">PMC8248252</ArticleId><ArticleId IdType="pubmed">34145166</ArticleId></ArticleIdList></Reference><Reference><Citation>Kory P., Meduri G.U., Varon J., Iglesias J., Marik P.E. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. Am. J. Ther. 2021;28:e299&#x2013;e318. doi: 10.1097/MJT.0000000000001377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MJT.0000000000001377</ArticleId><ArticleId IdType="pmc">PMC8088823</ArticleId><ArticleId IdType="pubmed">34375047</ArticleId></ArticleIdList></Reference><Reference><Citation>Griesel M., Wagner C., Mikolajewska A., Stegemann M., Fichtner F., Metzendorf M.-I., Nair A.A., Daniel J., Fischer A.-L., Skoetz N. Inhaled Corticosteroids for the Treatment of COVID-19. Cochrane Database Syst. Rev. 2022;3:CD015125. doi: 10.1002/14651858.CD015125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD015125</ArticleId><ArticleId IdType="pmc">PMC8905579</ArticleId><ArticleId IdType="pubmed">35262185</ArticleId></ArticleIdList></Reference><Reference><Citation>van Paassen J., Vos J.S., Hoekstra E.M., Neumann K.M.I., Boot P.C., Arbous S.M. Corticosteroid Use in COVID-19 Patients: A Systematic Review and Meta-Analysis on Clinical Outcomes. Crit. Care. 2020;24:696. doi: 10.1186/s13054-020-03400-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03400-9</ArticleId><ArticleId IdType="pmc">PMC7735177</ArticleId><ArticleId IdType="pubmed">33317589</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel N., Goyal N., Nagaraja R., Kumar R. Systemic Corticosteroids for Management of &#x2018;Long-COVID&#x2019;: An Evaluation after 3 Months of Treatment. Monaldi Arch. Chest Dis. 2022;92 doi: 10.4081/monaldi.2021.1981.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/monaldi.2021.1981</ArticleId><ArticleId IdType="pubmed">34730322</ArticleId></ArticleIdList></Reference><Reference><Citation>Mor&#xe1;n Blanco J.I., Alvarenga Bonilla J.A., Homma S., Suzuki K., Fremont-Smith P., Villar G&#xf3;mez de las Heras K. Antihistamines and Azithromycin as a Treatment for COVID-19 on Primary Health Care&#x2014;A Retrospective Observational Study in Elderly Patients. Pulm. Pharmacol. Ther. 2021;67:101989. doi: 10.1016/j.pupt.2021.101989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pupt.2021.101989</ArticleId><ArticleId IdType="pmc">PMC7833340</ArticleId><ArticleId IdType="pubmed">33465426</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto M.D., Lambert N., Downs C.A., Abrahim H., Hughes T.D., Rahmani A.M., Burton C.W., Chakraborty R. Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection. J. Nurse Pract. 2022;18:335&#x2013;338. doi: 10.1016/j.nurpra.2021.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurpra.2021.12.016</ArticleId><ArticleId IdType="pmc">PMC8820139</ArticleId><ArticleId IdType="pubmed">35153633</ArticleId></ArticleIdList></Reference><Reference><Citation>Reznikov L.R., Norris M.H., Vashisht R., Bluhm A.P., Li D., Liao Y.-S.J., Brown A., Butte A.J., Ostrov D.A. Identification of Antiviral Antihistamines for COVID-19 Repurposing. Biochem. Biophys. Res. Commun. 2021;538:173&#x2013;179. doi: 10.1016/j.bbrc.2020.11.095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.11.095</ArticleId><ArticleId IdType="pmc">PMC7713548</ArticleId><ArticleId IdType="pubmed">33309272</ArticleId></ArticleIdList></Reference><Reference><Citation>Tantry U.S., Bliden K.P., Gurbel P.A. Further Evidence for the Use of Aspirin in COVID-19. Int. J. Cardiol. 2022;346:107&#x2013;108. doi: 10.1016/j.ijcard.2021.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2021.11.021</ArticleId><ArticleId IdType="pmc">PMC8585554</ArticleId><ArticleId IdType="pubmed">34774888</ArticleId></ArticleIdList></Reference><Reference><Citation>Choubey A., Dehury B., Kumar S., Medhi B., Mondal P. Naltrexone a Potential Therapeutic Candidate for COVID-19. J. Biomol. Struct. Dyn. 2022;40:963&#x2013;970. doi: 10.1080/07391102.2020.1820379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1820379</ArticleId><ArticleId IdType="pmc">PMC7544934</ArticleId><ArticleId IdType="pubmed">32930058</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Kelly B., Vidal L., McHugh T., Woo J., Avramovic G., Lambert J.S. Safety and Efficacy of Low Dose Naltrexone in a Long Covid Cohort; an Interventional Pre-Post Study. Brain. Behav. Immun. Health. 2022;24:100485. doi: 10.1016/j.bbih.2022.100485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100485</ArticleId><ArticleId IdType="pmc">PMC9250701</ArticleId><ArticleId IdType="pubmed">35814187</ArticleId></ArticleIdList></Reference><Reference><Citation>Karatza E., Ismailos G., Karalis V. Colchicine for the Treatment of COVID-19 Patients: Efficacy, Safety, and Model Informed Dosage Regimens. Xenobiotica. 2021;51:643&#x2013;656. doi: 10.1080/00498254.2021.1909782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00498254.2021.1909782</ArticleId><ArticleId IdType="pmc">PMC8054498</ArticleId><ArticleId IdType="pubmed">33845715</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu L., Lo C.-H., Shen M., Chiu N., Aggarwal R., Lee J., Choi Y.-G., Lam H., Prsic E.H., Chow R., et al. Colchicine Use in Patients with COVID-19: A Systematic Review and Meta-Analysis. PLoS ONE. 2021;16:e0261358. doi: 10.1371/journal.pone.0261358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0261358</ArticleId><ArticleId IdType="pmc">PMC8714120</ArticleId><ArticleId IdType="pubmed">34962939</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabbani A.B., Parikh R.V., Rafique A.M. Colchicine for the Treatment of Myocardial Injury in Patients With Coronavirus Disease 2019 (COVID-19)&#x2014;An Old Drug With New Life? JAMA Netw. Open. 2020;3:e2013556. doi: 10.1001/jamanetworkopen.2020.13556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.13556</ArticleId><ArticleId IdType="pubmed">32579190</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiolet A.T.L., Opstal T.S.J., Mosterd A., Eikelboom J.W., Jolly S.S., Keech A.C., Kelly P., Tong D.C., Layland J., Nidorf S.M., et al. Efficacy and Safety of Low-Dose Colchicine in Patients with Coronary Disease: A Systematic Review and Meta-Analysis of Randomized Trials. Eur. Heart J. 2021;42:2765&#x2013;2775. doi: 10.1093/eurheartj/ehab115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab115</ArticleId><ArticleId IdType="pubmed">33769515</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim S., Lowe J.R., Bramante C.T., Shah S., Klatt N.R., Sherwood N., Aronne L., Puskarich M., Tamariz L., Palacio A., et al. Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit. Front. Endocrinol. 2021;12:587801. doi: 10.3389/fendo.2021.587801.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.587801</ArticleId><ArticleId IdType="pmc">PMC8342037</ArticleId><ArticleId IdType="pubmed">34367059</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante C.T., Buse J.B., Liebovitz D.M., Nicklas J.L., Puskarich M.A., Cohen K., Belani H., Anderson B., Huling J.D., Tignanelli C.J., et al. Outpatient Treatment of COVID-19 with Metformin, Ivermectin, and Fluvoxamine and the Development of Long Covid over 10-Month Follow-Up. medRxiv. 2022 doi: 10.1101/2022.12.21.22283753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.12.21.22283753</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrea L., Verde L., Grant W.B., Frias-Toral E., Sarno G., Vetrani C., Ceriani F., Garcia-Velasquez E., Contreras-Brice&#xf1;o J., Savastano S., et al. Vitamin D: A Role Also in Long COVID-19? Nutrients. 2022;14:1625. doi: 10.3390/nu14081625.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14081625</ArticleId><ArticleId IdType="pmc">PMC9028162</ArticleId><ArticleId IdType="pubmed">35458189</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;nen M.S., Alayl&#x131;o&#x11f;lu M., Durcan E., &#xd6;zdemir Y., &#x15e;ahin S., Konuko&#x11f;lu D., Nohut O.K., &#xdc;rkmez S., K&#xfc;&#xe7;&#xfc;kece B., Balkan &#x130;.&#x130;., et al. Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1. Nutrients. 2021;13:4047. doi: 10.3390/nu13114047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13114047</ArticleId><ArticleId IdType="pmc">PMC8618389</ArticleId><ArticleId IdType="pubmed">34836309</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C., Kraft K. Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue. Nutrients. 2021;13:1154. doi: 10.3390/nu13041154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13041154</ArticleId><ArticleId IdType="pmc">PMC8066596</ArticleId><ArticleId IdType="pubmed">33807280</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C., Kraft K. Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C. Front. Pharm. 2022;13:899198. doi: 10.3389/fphar.2022.899198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.899198</ArticleId><ArticleId IdType="pmc">PMC9100929</ArticleId><ArticleId IdType="pubmed">35571085</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M., Calvani R., Picca A., Ciciarello F., Galluzzo V., Coelho-J&#xfa;nior H.J., Di Giorgio A., Di Mario C., Gervasoni J., Gremese E., et al. Effects of L-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial. Nutrients. 2022;14:4984. doi: 10.3390/nu14234984.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14234984</ArticleId><ArticleId IdType="pmc">PMC9738241</ArticleId><ArticleId IdType="pubmed">36501014</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo R., Trimarco V., Mone P., Alo&#xe8; T., Capra Marzani M., Diana A., Fazio G., Mallardo M., Maniscalco M., Marazzi G., et al. Combining L-Arginine with Vitamin C Improves Long-COVID Symptoms: The LINCOLN Survey. Pharm. Res. 2022;183:106360. doi: 10.1016/j.phrs.2022.106360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2022.106360</ArticleId><ArticleId IdType="pmc">PMC9295384</ArticleId><ArticleId IdType="pubmed">35868478</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangge H., Prueller F., Dawczynski C., Curcic P., Sloup Z., Holter M., Herrmann M., Meinitzer A. Dramatic Decrease of Vitamin K2 Subtype Menaquinone-7 in COVID-19 Patients. Antioxidants. 2022;11:1235. doi: 10.3390/antiox11071235.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11071235</ArticleId><ArticleId IdType="pmc">PMC9312339</ArticleId><ArticleId IdType="pubmed">35883726</ArticleId></ArticleIdList></Reference><Reference><Citation>Debnath U., Dewaker V., Prabhakar Y.S., Bhattacharyya P., Mandal A. Conformational Perturbation of SARS-CoV-2 Spike Protein Using N-Acetyl Cysteine, a Molecular Scissor: A Probable Strategy to Combat COVID-19. ChemRxiv. 2021 doi: 10.26434/chemrxiv.12687923.v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.26434/chemrxiv.12687923.v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Z., Puyo C.A. N-Acetylcysteine to Combat COVID-19: An Evidence Review. Clin. Risk Manag. 2020;16:1047&#x2013;1055. doi: 10.2147/TCRM.S273700.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TCRM.S273700</ArticleId><ArticleId IdType="pmc">PMC7649937</ArticleId><ArticleId IdType="pubmed">33177829</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong K.K., Lee S.W.H., Kua K.P. N-Acetylcysteine as Adjuvant Therapy for COVID-19&#x2014;A Perspective on the Current State of the Evidence. J. Inflamm. Res. 2021;14:2993&#x2013;3013. doi: 10.2147/JIR.S306849.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S306849</ArticleId><ArticleId IdType="pmc">PMC8274825</ArticleId><ArticleId IdType="pubmed">34262324</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta P., Dutta S. N-Acetyl Cysteine as a Potential Regulator of SARS-CoV-2-Induced Male Reproductive Disruptions. Middle East Fertil. Soc. J. 2022;27:14. doi: 10.1186/s43043-022-00104-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43043-022-00104-8</ArticleId><ArticleId IdType="pmc">PMC9197722</ArticleId><ArticleId IdType="pubmed">35730047</ArticleId></ArticleIdList></Reference><Reference><Citation>Debnath U., Mitra A., Dewaker V., Prabhakar Y.S., Tadala R., Krishnan K., Wagh P., Velusamy U., Subramani C., Agarwal S., et al. N-Acetyl Cysteine: A Tool to Perturb SARS-CoV-2 Spike Protein Conformation. ChemRxiv. 2021 doi: 10.26434/chemrxiv.12687923.v2.</Citation><ArticleIdList><ArticleId IdType="doi">10.26434/chemrxiv.12687923.v2</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin A.N. The Role of Glutathione Deficiency and MSIDS Variables in Long COVID-19.  [(accessed on 30 September 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT05371288.</Citation></Reference><Reference><Citation>Guloyan V., Oganesian B., Baghdasaryan N., Yeh C., Singh M., Guilford F., Ting Y.-S., Venketaraman V. Glutathione Supplementation as an Adjunctive Therapy in COVID-19. Antioxidants. 2020;9:914. doi: 10.3390/antiox9100914.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9100914</ArticleId><ArticleId IdType="pmc">PMC7601802</ArticleId><ArticleId IdType="pubmed">32992775</ArticleId></ArticleIdList></Reference><Reference><Citation>Polonikov A. Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients. ACS Infect. Dis. 2020;6:1558&#x2013;1562. doi: 10.1021/acsinfecdis.0c00288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.0c00288</ArticleId><ArticleId IdType="pubmed">32463221</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvagno F., Vernone A., Pescarmona G.P. The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19. Antioxidants. 2020;9:624. doi: 10.3390/antiox9070624.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9070624</ArticleId><ArticleId IdType="pmc">PMC7402141</ArticleId><ArticleId IdType="pubmed">32708578</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardinali D.P., Brown G.M., Pandi-Perumal S.R. Possible Application of Melatonin in Long COVID. Biomolecules. 2022;12:1646. doi: 10.3390/biom12111646.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12111646</ArticleId><ArticleId IdType="pmc">PMC9687267</ArticleId><ArticleId IdType="pubmed">36358996</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan S.-H., Lee H.-Z., Chao C.-M., Chang S.-P., Lu L.-C., Lai C.-C. Efficacy of Melatonin in the Treatment of Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J. Med. Virol. 2022;94:2102&#x2013;2107. doi: 10.1002/jmv.27595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27595</ArticleId><ArticleId IdType="pmc">PMC9015545</ArticleId><ArticleId IdType="pubmed">35032042</ArticleId></ArticleIdList></Reference><Reference><Citation>Derosa G., Maffioli P., D&#x2019;Angelo A., Di Pierro F. A Role for Quercetin in Coronavirus Disease 2019 (COVID-19) Phytother. Res. 2021;35:1230&#x2013;1236. doi: 10.1002/ptr.6887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6887</ArticleId><ArticleId IdType="pmc">PMC7675685</ArticleId><ArticleId IdType="pubmed">33034398</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuli H., Sood S., Pundir A., Choudhary D., Dhama K., Kaur G., Seth P., Vashishth A., Kumar P. Molecular Docking Studies of Apigenin, Kaempferol, and Quercetin as Potential Target against Spike Receptor Protein of SARS COV. J. Exp. Biol. Agric. Sci. 2022;10:144&#x2013;149. doi: 10.18006/2022.10(1).144.149.</Citation><ArticleIdList><ArticleId IdType="doi">10.18006/2022.10(1).144.149</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;nal H., Arslan B., &#xdc;&#xe7;&#xfc;nc&#xfc; Ergun N., Topuz &#x15e;., Yilmaz Semerci S., Kurnaz M.E., Molu Y.M., Bozkurt M.A., S&#xfc;ner N., Kocata&#x15f; A. Treatment of COVID-19 Patients with Quercetin: A Prospective, Single Center, Randomized, Controlled Trial. Turk. J. Biol. 2021;45:518&#x2013;529. doi: 10.3906/biy-2104-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/biy-2104-16</ArticleId><ArticleId IdType="pmc">PMC8573830</ArticleId><ArticleId IdType="pubmed">34803451</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan B., Fang S., Zhang J., Pan Y., Liu H., Wang Y., Li M., Liu L. Chinese Herbal Compounds against SARS-CoV-2: Puerarin and Quercetin Impair the Binding of Viral S-Protein to ACE2 Receptor. Comput. Struct. Biotechnol. J. 2020;18:3518&#x2013;3527. doi: 10.1016/j.csbj.2020.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2020.11.010</ArticleId><ArticleId IdType="pmc">PMC7657012</ArticleId><ArticleId IdType="pubmed">33200026</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjunath S.H., Thimmulappa R.K. Antiviral, Immunomodulatory, and Anticoagulant Effects of Quercetin and Its Derivatives: Potential Role in Prevention and Management of COVID-19. J. Pharm. Anal. 2022;12:29&#x2013;34. doi: 10.1016/j.jpha.2021.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpha.2021.09.009</ArticleId><ArticleId IdType="pmc">PMC8450231</ArticleId><ArticleId IdType="pubmed">34567823</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A., Iqtadar S., Mumtaz S.U., Heinrich M., Pascual-Figal D.A., Livingstone S., Abaidullah S. Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19&#x2014;Results From a Pilot Open-Label, Randomized Controlled Trial. Front. Pharm. 2022;13:898062. doi: 10.3389/fphar.2022.898062.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.898062</ArticleId><ArticleId IdType="pmc">PMC9211374</ArticleId><ArticleId IdType="pubmed">35747751</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho T.-Y., Wu S.-L., Chen J.-C., Li C.-C., Hsiang C.-Y. Emodin Blocks the SARS Coronavirus Spike Protein and Angiotensin-Converting Enzyme 2 Interaction. Antivir. Res. 2007;74:92&#x2013;101. doi: 10.1016/j.antiviral.2006.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2006.04.014</ArticleId><ArticleId IdType="pmc">PMC7114332</ArticleId><ArticleId IdType="pubmed">16730806</ArticleId></ArticleIdList></Reference><Reference><Citation>Maideen N.M.P. Prophetic Medicine-Nigella Sativa (Black Cumin Seeds)&#x2014;Potential Herb for COVID-19? J. Pharmacopunct. 2020;23:62&#x2013;70. doi: 10.3831/KPI.2020.23.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3831/KPI.2020.23.010</ArticleId><ArticleId IdType="pmc">PMC7338708</ArticleId><ArticleId IdType="pubmed">32685234</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M.T. Potential Benefits of Combination of Nigella Sativa and Zn Supplements to Treat COVID-19. J. Herb. Med. 2020;23:100382. doi: 10.1016/j.hermed.2020.100382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hermed.2020.100382</ArticleId><ArticleId IdType="pmc">PMC7313527</ArticleId><ArticleId IdType="pubmed">32834942</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A., Kanwar M., Das Mohapatra P.K., Saso L., Nicoletti M., Maiti S. Nigellidine (Nigella Sativa, Black-Cumin Seed) Docking to SARS CoV-2 Nsp3 and Host Inflammatory Proteins May Inhibit Viral Replication/Transcription and FAS-TNF Death Signal via TNFR &#xbd; Blocking. Nat. Prod. Res. 2021;36:5817&#x2013;5822. doi: 10.1080/14786419.2021.2018430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14786419.2021.2018430</ArticleId><ArticleId IdType="pubmed">34937447</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordo R., Zinellu A., Eid A.H., Pintus G. Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders. Molecules. 2021;26:856. doi: 10.3390/molecules26040856.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26040856</ArticleId><ArticleId IdType="pmc">PMC7915700</ArticleId><ArticleId IdType="pubmed">33562030</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasquereau S., Nehme Z., Haidar Ahmad S., Daouad F., Van Assche J., Wallet C., Schwartz C., Rohr O., Morot-Bizot S., Herbein G. Resveratrol Inhibits HcoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro. Viruses. 2021;13:354. doi: 10.3390/v13020354.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020354</ArticleId><ArticleId IdType="pmc">PMC7926471</ArticleId><ArticleId IdType="pubmed">33672333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramdani L.H., Bachari K. Potential Therapeutic Effects of Resveratrol against SARS-CoV-2. Acta Virol. 2020;64:276&#x2013;280. doi: 10.4149/av_2020_309.</Citation><ArticleIdList><ArticleId IdType="doi">10.4149/av_2020_309</ArticleId><ArticleId IdType="pubmed">32985211</ArticleId></ArticleIdList></Reference><Reference><Citation>McCreary M.R., Schnell P.M., Rhoda D.A. Randomized Double-Blind Placebo-Controlled Proof-of-Concept Trial of Resveratrol for Outpatient Treatment of Mild Coronavirus Disease (COVID-19) Sci. Rep. 2022;12:10978. doi: 10.1038/s41598-022-13920-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13920-9</ArticleId><ArticleId IdType="pmc">PMC9243086</ArticleId><ArticleId IdType="pubmed">35768453</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahedipour F., Hosseini S.A., Sathyapalan T., Majeed M., Jamialahmadi T., Al-Rasadi K., Banach M., Sahebkar A. Potential Effects of Curcumin in the Treatment of COVID-19 Infection. Phytother. Res. 2020;34:2911&#x2013;2920. doi: 10.1002/ptr.6738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6738</ArticleId><ArticleId IdType="pmc">PMC7276879</ArticleId><ArticleId IdType="pubmed">32430996</ArticleId></ArticleIdList></Reference><Reference><Citation>Suravajhala R., Parashar A., Malik B., Nagaraj A.V., Padmanaban G., Kishor P.K., Polavarapu R., Suravajhala P. Comparative Docking Studies on Curcumin with COVID-19 Proteins. Preprints. 2020:2020050439. doi: 10.20944/preprints202005.0439.v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.20944/preprints202005.0439.v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Jena A.B., Kanungo N., Nayak V., Chainy G.B.N., Dandapat J. Catechin and Curcumin Interact with S Protein of SARS-CoV2 and ACE2 of Human Cell Membrane: Insights from Computational Studies. Sci. Rep. 2021;11:2043. doi: 10.1038/s41598-021-81462-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-81462-7</ArticleId><ArticleId IdType="pmc">PMC7820253</ArticleId><ArticleId IdType="pubmed">33479401</ArticleId></ArticleIdList></Reference><Reference><Citation>Rattis B.A.C., Ramos S.G., Celes M.R.N. Curcumin as a Potential Treatment for COVID-19. Front. Pharmacol. 2021;12:2085. doi: 10.3389/fphar.2021.675287.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.675287</ArticleId><ArticleId IdType="pmc">PMC8138567</ArticleId><ArticleId IdType="pubmed">34025433</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahedian-Azimi A., Abbasifard M., Rahimi-Bashar F., Guest P.C., Majeed M., Mohammadi A., Banach M., Jamialahmadi T., Sahebkar A. Effectiveness of Curcumin on Outcomes of Hospitalized COVID-19 Patients: A Systematic Review of Clinical Trials. Nutrients. 2022;14:256. doi: 10.3390/nu14020256.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14020256</ArticleId><ArticleId IdType="pmc">PMC8779570</ArticleId><ArticleId IdType="pubmed">35057437</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelazeem B., Awad A.K., Elbadawy M.A., Manasrah N., Malik B., Yousaf A., Alqasem S., Banour S., Abdelmohsen S.M. The Effects of Curcumin as Dietary Supplement for Patients with COVID-19: A Systematic Review of Randomized Clinical Trials. Drug Discov. Ther. 2022;16:14&#x2013;22. doi: 10.5582/ddt.2022.01017.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/ddt.2022.01017</ArticleId><ArticleId IdType="pubmed">35264470</ArticleId></ArticleIdList></Reference><Reference><Citation>Iotti S., Wolf F., Mazur A., Maier J.A. The COVID-19 Pandemic: Is There a Role for Magnesium? Hypotheses and Perspectives. Magnes. Res. 2020;33:21&#x2013;27. doi: 10.1684/mrh.2020.0465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1684/mrh.2020.0465</ArticleId><ArticleId IdType="pubmed">32554340</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang C.-F., Ding H., Jiao R.-Q., Wu X.-X., Kong L.-D. Possibility of Magnesium Supplementation for Supportive Treatment in Patients with COVID-19. Eur. J. Pharm. 2020;886:173546. doi: 10.1016/j.ejphar.2020.173546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2020.173546</ArticleId><ArticleId IdType="pmc">PMC7486870</ArticleId><ArticleId IdType="pubmed">32931782</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero-Romero F., Mercado M., Rodriguez-Moran M., Ram&#xed;rez-Renteria C., Mart&#xed;nez-Aguilar G., Marrero-Rodr&#xed;guez D., Ferreira-Hermosillo A., Simental-Mend&#xed;a L.E., Remba-Shapiro I., Gamboa-G&#xf3;mez C.I., et al. Magnesium-to-Calcium Ratio and Mortality from COVID-19. Nutrients. 2022;14:1686. doi: 10.3390/nu14091686.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14091686</ArticleId><ArticleId IdType="pmc">PMC9414200</ArticleId><ArticleId IdType="pubmed">36014949</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Tang L., Liu X., Li Y., Chen J., Huang W., Liu M. Populations in Low-Magnesium Areas Were Associated with Higher Risk of Infection in COVID-19&#x2032;s Early Transmission: A Nationwide Retrospective Cohort Study in the United States. Nutrients. 2022;14:909. doi: 10.3390/nu14040909.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14040909</ArticleId><ArticleId IdType="pmc">PMC8875017</ArticleId><ArticleId IdType="pubmed">35215558</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabatabaeizadeh S.-A. Zinc Supplementation and COVID-19 Mortality: A Meta-Analysis. Eur. J. Med. Res. 2022;27:70. doi: 10.1186/s40001-022-00694-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-022-00694-z</ArticleId><ArticleId IdType="pmc">PMC9125011</ArticleId><ArticleId IdType="pubmed">35599332</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal A., Squitti R., Picozza M., Pawar A., Rongioletti M., Dutta A.K., Sahoo S., Goswami K., Sharma P., Prasad R. Zinc and COVID-19: Basis of Current Clinical Trials. Biol. Trace. Elem. Res. 2021;199:2882&#x2013;2892. doi: 10.1007/s12011-020-02437-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12011-020-02437-9</ArticleId><ArticleId IdType="pmc">PMC7580816</ArticleId><ArticleId IdType="pubmed">33094446</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A.S., Malysa A., Bepler G., Fribley A., Bao B. The Mechanisms of Zinc Action as a Potent Anti-Viral Agent: The Clinical Therapeutic Implication in COVID-19. Antioxidants. 2022;11:1862. doi: 10.3390/antiox11101862.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11101862</ArticleId><ArticleId IdType="pmc">PMC9598180</ArticleId><ArticleId IdType="pubmed">36290585</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrosa L.F.C., Barros A.N.A.B., Leite-Lais L. Nutritional Risk of Vitamin D, Vitamin C, Zinc, and Selenium Deficiency on Risk and Clinical Outcomes of COVID-19: A Narrative Review. Clin. Nutr. ESPEN. 2022;47:9&#x2013;27. doi: 10.1016/j.clnesp.2021.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2021.11.003</ArticleId><ArticleId IdType="pmc">PMC8571905</ArticleId><ArticleId IdType="pubmed">35063248</ArticleId></ArticleIdList></Reference><Reference><Citation>Balboni E., Zagnoli F., Filippini T., Fairweather-Tait S.J., Vinceti M. Zinc and Selenium Supplementation in COVID-19 Prevention and Treatment: A Systematic Review of the Experimental Studies. J. Trace Elem. Med. Biol. 2022;71:126956. doi: 10.1016/j.jtemb.2022.126956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtemb.2022.126956</ArticleId><ArticleId IdType="pmc">PMC8853960</ArticleId><ArticleId IdType="pubmed">35217499</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., Zhang L., Zeng R., Luo D., Jiang R., Wu H., Zhuo Z., Yang Q., Li J., Leung F.W., et al. Associations of Habitual Fish Oil Use with Risk of SARS-CoV-2 Infection and COVID-19-Related Outcomes in UK: National Population Based Cohort Study. medRxiv. 2022 doi: 10.1101/2022.09.14.22279933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.09.14.22279933</ArticleId></ArticleIdList></Reference><Reference><Citation>Merritt R.J., Bhardwaj V., Jami M.M. Fish Oil and COVID-19 Thromboses. J. Vasc. Surg. Venous Lymphat. Disord. 2020;8:1120. doi: 10.1016/j.jvsv.2020.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvsv.2020.07.002</ArticleId><ArticleId IdType="pmc">PMC7362817</ArticleId><ArticleId IdType="pubmed">32682081</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrinhas R.S., Calder P.C., Lemos G.O., Waitzberg D.L. Parenteral Fish Oil: An Adjuvant Pharmacotherapy for Coronavirus Disease 2019? Nutrition. 2021;81:110900. doi: 10.1016/j.nut.2020.110900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2020.110900</ArticleId><ArticleId IdType="pmc">PMC7836308</ArticleId><ArticleId IdType="pubmed">32738510</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Cholevas C., Polyzoidis K., Politis A. Long-COVID Syndrome-associated Brain Fog and Chemofog: Luteolin to the Rescue. Biofactors. 2021;47:232&#x2013;241. doi: 10.1002/biof.1726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1726</ArticleId><ArticleId IdType="pmc">PMC8250989</ArticleId><ArticleId IdType="pubmed">33847020</ArticleId></ArticleIdList></Reference><Reference><Citation>Shadrack D.M., Deogratias G., Kiruri L.W., Onoka I., Vianney J.-M., Swai H., Nyandoro S.S. Luteolin: A Blocker of SARS-CoV-2 Cell Entry Based on Relaxed Complex Scheme, Molecular Dynamics Simulation, and Metadynamics. J. Mol. Model. 2021;27:221. doi: 10.1007/s00894-021-04833-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00894-021-04833-x</ArticleId><ArticleId IdType="pmc">PMC8264176</ArticleId><ArticleId IdType="pubmed">34236507</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. COVID-19, Pulmonary Mast Cells, Cytokine Storms, and Beneficial Actions of Luteolin. Biofactors. 2020;46:306&#x2013;308. doi: 10.1002/biof.1633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1633</ArticleId><ArticleId IdType="pmc">PMC7267424</ArticleId><ArticleId IdType="pubmed">32339387</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Stadio A., D&#x2019;Ascanio L., Vaira L.A., Cantone E., De Luca P., Cingolani C., Motta G., De Riu G., Vitelli F., Spriano G., et al. Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial. Curr. Neuropharmacol. 2022;20:2001&#x2013;2012. doi: 10.2174/1570159X20666220420113513.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X20666220420113513</ArticleId><ArticleId IdType="pmc">PMC9886808</ArticleId><ArticleId IdType="pubmed">35450527</ArticleId></ArticleIdList></Reference><Reference><Citation>Masiello P., Novelli M., Beffy P., Menegazzi M. Can Hypericum Perforatum (SJW) Prevent Cytokine Storm in COVID-19 Patients? Phytother. Res. 2020;34:1471&#x2013;1473. doi: 10.1002/ptr.6764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6764</ArticleId><ArticleId IdType="pmc">PMC7300500</ArticleId><ArticleId IdType="pubmed">32501634</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed F.F., Anhlan D., Sch&#xf6;fb&#xe4;nker M., Schreiber A., Classen N., Hensel A., Hempel G., Scholz W., K&#xfc;hn J., Hrincius E.R., et al. Hypericum Perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2. Pharmaceuticals. 2022;15:530. doi: 10.3390/ph15050530.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15050530</ArticleId><ArticleId IdType="pmc">PMC9146521</ArticleId><ArticleId IdType="pubmed">35631357</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdoorn B.P., Evans T.K., Hanson G.J., Zhu Y., Langhi Prata L.G.P., Pignolo R.J., Atkinson E.J., Wissler-Gerdes E.O., Kuchel G.A., Mannick J.B., et al. Fisetin for COVID-19 in Skilled Nursing Facilities: Senolytic Trials in the COVID Era. J. Am. Geriatr. Soc. 2021;69:3023&#x2013;3033. doi: 10.1111/jgs.17416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17416</ArticleId><ArticleId IdType="pmc">PMC8447437</ArticleId><ArticleId IdType="pubmed">34375437</ArticleId></ArticleIdList></Reference><Reference><Citation>Oladele J.O., Oyeleke O.M., Oladele O.T., Olowookere B.D., Oso B.J., Oladiji A.T. Kolaviron (Kolaflavanone), Apigenin, Fisetin as Potential Coronavirus Inhibitors: In Silico Investigatio. Res. Sq. 2020 doi: 10.21203/rs.3.rs-51350/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-51350/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey P., Rane J.S., Chatterjee A., Kumar A., Khan R., Prakash A., Ray S. Targeting SARS-CoV-2 Spike Protein of COVID-19 with Naturally Occurring Phytochemicals: An in Silico Study for Drug Development. J. Biomol. Struct. Dyn. 2021;39:6306&#x2013;6316. doi: 10.1080/07391102.2020.1796811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1796811</ArticleId><ArticleId IdType="pmc">PMC7441770</ArticleId><ArticleId IdType="pubmed">32698689</ArticleId></ArticleIdList></Reference><Reference><Citation>Willyard C. How Anti-Ageing Drugs Could Boost COVID Vaccines in Older People. Nature. 2020;586:352&#x2013;354. doi: 10.1038/d41586-020-02856-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02856-7</ArticleId><ArticleId IdType="pubmed">33057226</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey D., Dey N., Ghosh S., Chandrasekaran N., Mukherjee A., Thomas J. Potential Combination Therapy Using Twenty Phytochemicals from Twenty Plants to Prevent SARS-CoV-2 Infection: An in Silico Approach. Virusdisease. 2021;32:108&#x2013;116. doi: 10.1007/s13337-021-00658-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13337-021-00658-7</ArticleId><ArticleId IdType="pmc">PMC8021291</ArticleId><ArticleId IdType="pubmed">33842675</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins J., Hires C., Keenan L., Dunne E. Aromatherapy Blend of Thyme, Orange, Clove Bud, and Frankincense Boosts Energy Levels in Post-COVID-19 Female Patients: A Randomized, Double-Blinded, Placebo Controlled Clinical Trial. Complement. Ther. Med. 2022;67:102823. doi: 10.1016/j.ctim.2022.102823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctim.2022.102823</ArticleId><ArticleId IdType="pmc">PMC8949693</ArticleId><ArticleId IdType="pubmed">35341944</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajri M. The Potential of Moringa Oleifera as Immune Booster against COVID 19. IOP Conf. Ser. Earth Environ. Sci. 2021;807:022008. doi: 10.1088/1755-1315/807/2/022008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/1755-1315/807/2/022008</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachar S.C., Mazumder K., Bachar R., Aktar A., Al Mahtab M. A Review of Medicinal Plants with Antiviral Activity Available in Bangladesh and Mechanistic Insight Into Their Bioactive Metabolites on SARS-CoV-2, HIV and HBV. Front. Pharm. 2021;12:732891. doi: 10.3389/fphar.2021.732891.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.732891</ArticleId><ArticleId IdType="pmc">PMC8606584</ArticleId><ArticleId IdType="pubmed">34819855</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaves O.A., Lima C.R., Fintelman-Rodrigues N., Sacramento C.Q., de Freitas C.S., Vazquez L., Temerozo J.R., Rocha M.E.N., Dias S.S.G., Carels N., et al. Agathisflavone, a Natural Biflavonoid That Inhibits SARS-CoV-2 Replication by Targeting Its Proteases. Int. J. Biol. Macromol. 2022;222:1015&#x2013;1026. doi: 10.1016/j.ijbiomac.2022.09.204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2022.09.204</ArticleId><ArticleId IdType="pmc">PMC9525951</ArticleId><ArticleId IdType="pubmed">36183752</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssens J., Laekeman G.M., Pieters L.A., Totte J., Herman A.G., Vlietinck A.J. Nutmeg Oil: Identification and Quantitation of Its Most Active Constituents as Inhibitors of Platelet Aggregation. J. Ethnopharmacol. 1990;29:179&#x2013;188. doi: 10.1016/0378-8741(90)90054-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0378-8741(90)90054-W</ArticleId><ArticleId IdType="pubmed">2115612</ArticleId></ArticleIdList></Reference><Reference><Citation>Le-Trilling V.T.K., Mennerich D., Schuler C., Sakson R., Lill J.K., Kasarla S.S., Kopczynski D., Loroch S., Flores-Martinez Y., Katschinski B., et al. Identification of Herbal Teas and Their Compounds Eliciting Antiviral Activity against SARS-CoV-2 in Vitro. BMC Biol. 2022;20:264. doi: 10.1186/s12915-022-01468-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-022-01468-z</ArticleId><ArticleId IdType="pmc">PMC9708519</ArticleId><ArticleId IdType="pubmed">36447206</ArticleId></ArticleIdList></Reference><Reference><Citation>Le-Trilling V.T.K., Mennerich D., Schuler C., Sakson R., Lill J.K., Kopczynski D., Loroch S., Flores-Martinez Y., Katschinski B., Wohlgemuth K., et al. Universally Available Herbal Teas Based on Sage and Perilla Elicit Potent Antiviral Activity against SARS-CoV-2 Variants of Concern by HMOX-1 Upregulation in Human Cells. bioRxiv. 2022 doi: 10.1101/2020.11.18.388710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.18.388710</ArticleId></ArticleIdList></Reference><Reference><Citation>Omoboyowa D.A., Balogun T.A., Chukwudozie O., Nweze V., Saibu O., Abdulahi A. SARS-COV-2 Spike Glycoprotein as Inhibitory Target for Insilico Screening of Natural Compound. Biointerface Res. Appl. Chem. 2021;11:14974&#x2013;14985.</Citation></Reference><Reference><Citation>Kumari A., Rajput V.S., Nagpal P., Kukrety H., Grover S., Grover A. Dual Inhibition of SARS-CoV-2 Spike and Main Protease through a Repurposed Drug, Rutin. J. Biomol. Struct. Dyn. 2022;40:4987&#x2013;4999. doi: 10.1080/07391102.2020.1864476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1864476</ArticleId><ArticleId IdType="pmc">PMC7784834</ArticleId><ArticleId IdType="pubmed">33357073</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagoor Meeran M.F., Seenipandi A., Javed H., Sharma C., Hashiesh H.M., Goyal S.N., Jha N.K., Ojha S. Can Limonene Be a Possible Candidate for Evaluation as an Agent or Adjuvant against Infection, Immunity, and Inflammation in COVID-19? Heliyon. 2021;7:e05703. doi: 10.1016/j.heliyon.2020.e05703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2020.e05703</ArticleId><ArticleId IdType="pmc">PMC7810623</ArticleId><ArticleId IdType="pubmed">33490659</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed M.E., Tawfeek N., Elbaramawi S.S., Fikry E. Agathis Robusta Bark Essential Oil Effectiveness against COVID-19: Chemical Composition, In Silico and In Vitro Approaches. Plants. 2022;11:663. doi: 10.3390/plants11050663.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/plants11050663</ArticleId><ArticleId IdType="pmc">PMC8912836</ArticleId><ArticleId IdType="pubmed">35270131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziyaei K., Ataie Z., Mokhtari M., Adrah K., Daneshmehr M.A. An Insight to the Therapeutic Potential of Algae-Derived Sulfated Polysaccharides and Polyunsaturated Fatty Acids: Focusing on the COVID-19. Int. J. Biol. Macromol. 2022;209:244&#x2013;257. doi: 10.1016/j.ijbiomac.2022.03.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2022.03.063</ArticleId><ArticleId IdType="pmc">PMC8924028</ArticleId><ArticleId IdType="pubmed">35306019</ArticleId></ArticleIdList></Reference><Reference><Citation>Sami N., Ahmad R., Fatma T. Exploring Algae and Cyanobacteria as a Promising Natural Source of Antiviral Drug against SARS-CoV-2. Biomed. J. 2021;44:54&#x2013;62. doi: 10.1016/j.bj.2020.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bj.2020.11.014</ArticleId><ArticleId IdType="pmc">PMC7836382</ArticleId><ArticleId IdType="pubmed">33640332</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzachor A., Rozen O., Khatib S., Jensen S., Avni D. Photosynthetically Controlled Spirulina, but Not Solar Spirulina, Inhibits TNF-&#x3b1; Secretion: Potential Implications for COVID-19-Related Cytokine Storm Therapy. Mar. Biotechnol. 2021;23:149&#x2013;155. doi: 10.1007/s10126-021-10020-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10126-021-10020-z</ArticleId><ArticleId IdType="pmc">PMC7874025</ArticleId><ArticleId IdType="pubmed">33566210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Singh R.P., Kumar I., Yadav P., Singh S.K., Kaushalendra, Singh P.K., Gupta R.K., Singh S.M., Kesawat M.S., et al. Algal Metabolites Can Be an Immune Booster against COVID-19 Pandemic. Antioxidants. 2022;11:452. doi: 10.3390/antiox11030452.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11030452</ArticleId><ArticleId IdType="pmc">PMC8944855</ArticleId><ArticleId IdType="pubmed">35326102</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran H.T.T., Gigl M., Le N.P.K., Dawid C., Lamy E. In Vitro Effect of Taraxacum Officinale Leaf Aqueous Extract on the Interaction between ACE2 Cell Surface Receptor and SARS-CoV-2 Spike Protein D614 and Four Mutants. Pharmaceuticals. 2021;14:1055. doi: 10.3390/ph14101055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14101055</ArticleId><ArticleId IdType="pmc">PMC8538008</ArticleId><ArticleId IdType="pubmed">34681279</ArticleId></ArticleIdList></Reference><Reference><Citation>Vavilova V.P., Vavilov A.M., Tsarkova S.A., Nesterova O.L., Kulyabina A.A., Yakhno N.B., Anisimova A.V., Vavilov V.A., Elkina E.N., Dobryak T.A. One of the possibilities of optimizing the therapy of a new coronavirus infection in children with the inclusion of an extract from marshmallow root, chamomile flowers, horsetail grass, walnut leaves, yarrow grass, oak bark and dandelion grass: Prospective open comparative cohort study. Pediatr. Cons. Med. 2022;4:322&#x2013;330. doi: 10.26442/26586630.2022.4.201970.</Citation><ArticleIdList><ArticleId IdType="doi">10.26442/26586630.2022.4.201970</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas K., Ackermann M., Leifke A.L., Li W.W., P&#xf6;schl U., Fr&#xf6;hlich-Nowoisky J. Ceylon Cinnamon and Its Major Compound Cinnamaldehyde Can Limit Overshooting Inflammatory Signaling and Angiogenesis in Vitro: Implications for COVID-19 Treatment. bioRxiv. 2021 doi: 10.1101/2021.06.16.448642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.16.448642</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas K., Fr&#xf6;hlich-Nowoisky J., Oppitz N., Ackermann M. Cinnamon and Hop Extracts as Potential Immunomodulators for Severe COVID-19 Cases. Front. Plant Sci. 2021;12:589783. doi: 10.3389/fpls.2021.589783.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpls.2021.589783</ArticleId><ArticleId IdType="pmc">PMC7952639</ArticleId><ArticleId IdType="pubmed">33719281</ArticleId></ArticleIdList></Reference><Reference><Citation>Zareie A., Soleimani D., Askari G., Jamialahmadi T., Guest P.C., Bagherniya M., Sahebkar A. Cinnamon: A Promising Natural Product Against COVID-19. Adv. Exp. Med. Biol. 2021;1327:191&#x2013;195. doi: 10.1007/978-3-030-71697-4_15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-71697-4_15</ArticleId><ArticleId IdType="pubmed">34279839</ArticleId></ArticleIdList></Reference><Reference><Citation>Yakhchali M., Taghipour Z., Mirabzadeh Ardakani M., Alizadeh Vaghasloo M., Vazirian M., Sadrai S. Cinnamon and Its Possible Impact on COVID-19: The Viewpoint of Traditional and Conventional Medicine. Biomed. Pharm. 2021;143:112221. doi: 10.1016/j.biopha.2021.112221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.112221</ArticleId><ArticleId IdType="pmc">PMC8452493</ArticleId><ArticleId IdType="pubmed">34563952</ArticleId></ArticleIdList></Reference><Reference><Citation>Musazadeh V., Karimi A., Bagheri N., Jafarzadeh J., Sanaie S., Vajdi M., Karimi M., Niazkar H.R. The Favorable Impacts of Silibinin Polyphenols as Adjunctive Therapy in Reducing the Complications of COVID-19: A Review of Research Evidence and Underlying Mechanisms. Biomed. Pharmacother. 2022;154:113593. doi: 10.1016/j.biopha.2022.113593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.113593</ArticleId><ArticleId IdType="pmc">PMC9393179</ArticleId><ArticleId IdType="pubmed">36027611</ArticleId></ArticleIdList></Reference><Reference><Citation>Speciale A., Muscar&#xe0; C., Molonia M.S., Cimino F., Saija A., Giofr&#xe8; S.V. Silibinin as Potential Tool against SARS-Cov-2: In Silico Spike Receptor-Binding Domain and Main Protease Molecular Docking Analysis, and in Vitro Endothelial Protective Effects. Phytother. Res. 2021;35:4616&#x2013;4625. doi: 10.1002/ptr.7107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.7107</ArticleId><ArticleId IdType="pmc">PMC8251480</ArticleId><ArticleId IdType="pubmed">33822421</ArticleId></ArticleIdList></Reference><Reference><Citation>Intharuksa A., Arunotayanun W., Yooin W., Sirisa-ard P. A Comprehensive Review of Andrographis Paniculata (Burm. F.) Nees and Its Constituents as Potential Lead Compounds for COVID-19 Drug Discovery. Molecules. 2022;27:4479. doi: 10.3390/molecules27144479.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27144479</ArticleId><ArticleId IdType="pmc">PMC9316804</ArticleId><ArticleId IdType="pubmed">35889352</ArticleId></ArticleIdList></Reference><Reference><Citation>Sa-Ngiamsuntorn K., Suksatu A., Pewkliang Y., Thongsri P., Kanjanasirirat P., Manopwisedjaroen S., Charoensutthivarakul S., Wongtrakoongate P., Pitiporn S., Chaopreecha J., et al. Anti-SARS-CoV-2 Activity of Andrographis Paniculata Extract and Its Major Component Andrographolide in Human Lung Epithelial Cells and Cytotoxicity Evaluation in Major Organ Cell Representatives. J. Nat. Prod. 2021;84:1261&#x2013;1270. doi: 10.1021/acs.jnatprod.0c01324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jnatprod.0c01324</ArticleId><ArticleId IdType="pubmed">33844528</ArticleId></ArticleIdList></Reference><Reference><Citation>Murugan N.A., Pandian C.J., Jeyakanthan J. Computational Investigation on Andrographis Paniculata Phytochemicals to Evaluate Their Potency against SARS-CoV-2 in Comparison to Known Antiviral Compounds in Drug Trials. J. Biomol. Struct. Dyn. 2021;39:4415&#x2013;4426. doi: 10.1080/07391102.2020.1777901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1777901</ArticleId><ArticleId IdType="pmc">PMC7309306</ArticleId><ArticleId IdType="pubmed">32543978</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanwettiyanont J., Piriyachananusorn N., Sangsoi L., Boonsong B., Sunpapoa C., Tanamatayarat P., Na-Ek N., Kanchanasurakit S. Use of Andrographis Paniculata (Burm.f.) Wall. Ex Nees and Risk of Pneumonia in Hospitalised Patients with Mild Coronavirus Disease 2019: A Retrospective Cohort Study. Front. Med. 2022;9:947373. doi: 10.3389/fmed.2022.947373.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.947373</ArticleId><ArticleId IdType="pmc">PMC9399469</ArticleId><ArticleId IdType="pubmed">36035418</ArticleId></ArticleIdList></Reference><Reference><Citation>Ao Z., Chan M., Ouyang M.J., Olukitibi T.A., Mahmoudi M., Kobasa D., Yao X. Identification and Evaluation of the Inhibitory Effect of Prunella Vulgaris Extract on SARS-Coronavirus 2 Virus Entry. PLoS ONE. 2021;16:e0251649. doi: 10.1371/journal.pone.0251649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0251649</ArticleId><ArticleId IdType="pmc">PMC8189562</ArticleId><ArticleId IdType="pubmed">34106944</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomaa A.A., Abdel-Wadood Y.A. The Potential of Glycyrrhizin and Licorice Extract in Combating COVID-19 and Associated Conditions. Phytomed. Plus. 2021;1:100043. doi: 10.1016/j.phyplu.2021.100043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phyplu.2021.100043</ArticleId><ArticleId IdType="pmc">PMC7886629</ArticleId><ArticleId IdType="pubmed">35399823</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Sand L., Bormann M., Alt M., Schipper L., Heilingloh C.S., Steinmann E., Todt D., Dittmer U., Elsner C., Witzke O., et al. Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease. Viruses. 2021;13:609. doi: 10.3390/v13040609.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040609</ArticleId><ArticleId IdType="pmc">PMC8066091</ArticleId><ArticleId IdType="pubmed">33918301</ArticleId></ArticleIdList></Reference><Reference><Citation>Diomede L., Beeg M., Gamba A., Fumagalli O., Gobbi M., Salmona M. Can Antiviral Activity of Licorice Help Fight COVID-19 Infection? Biomolecules. 2021;11:855. doi: 10.3390/biom11060855.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11060855</ArticleId><ArticleId IdType="pmc">PMC8227143</ArticleId><ArticleId IdType="pubmed">34201172</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomaa A. Evaluation of The Potential Therapeutic Effects of Licorice and Boswellia Serrata Gum in Egyptian Patients With COVID-19 as a Complementary Medicine.  [(accessed on 30 September 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT04487964.</Citation></Reference><Reference><Citation>Ng S.L., Khaw K.-Y., Ong Y.S., Goh H.P., Kifli N., Teh S.P., Ming L.C., Kotra V., Goh B.H. Licorice: A Potential Herb in Overcoming SARS-CoV-2 Infections. J. Evid. Based. Integr. Med. 2021;26:2515690X21996662. doi: 10.1177/2515690X21996662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2515690X21996662</ArticleId><ArticleId IdType="pmc">PMC8020229</ArticleId><ArticleId IdType="pubmed">33787349</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi Y., Li J., Lai X., Zhang M., Kuang Y., Bao Y.-O., Yu R., Hong W., Muturi E., Xue H., et al. Natural Triterpenoids from Licorice Potently Inhibit SARS-CoV-2 Infection. J. Adv. Res. 2021;36:201&#x2013;210. doi: 10.1016/j.jare.2021.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2021.11.012</ArticleId><ArticleId IdType="pmc">PMC8620242</ArticleId><ArticleId IdType="pubmed">35116174</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakeeb N., Varkey P., Hynse A., Mandlecha A. Anti-Inflammatory Response of Cardamom Extract and Prediction of Therapeutic Window in COVID-19 Patients by Assessing Inflammatory Markers Using RT-PCR. Inflammopharmacology. 2022;30:883&#x2013;894. doi: 10.1007/s10787-022-00951-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-022-00951-x</ArticleId><ArticleId IdType="pmc">PMC8941370</ArticleId><ArticleId IdType="pubmed">35320494</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicidomini C., Roviello V., Roviello G.N. Molecular Basis of the Therapeutical Potential of Clove (Syzygium Aromaticum L.) and Clues to Its Anti-COVID-19 Utility. Molecules. 2021;26:1880. doi: 10.3390/molecules26071880.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26071880</ArticleId><ArticleId IdType="pmc">PMC8036487</ArticleId><ArticleId IdType="pubmed">33810416</ArticleId></ArticleIdList></Reference><Reference><Citation>Paidi R.K., Jana M., Raha S., McKay M., Sheinin M., Mishra R.K., Pahan K. Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses. J. Neuroimmune Pharm. 2021;16:743&#x2013;755. doi: 10.1007/s11481-021-10028-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-021-10028-1</ArticleId><ArticleId IdType="pmc">PMC8531902</ArticleId><ArticleId IdType="pubmed">34677731</ArticleId></ArticleIdList></Reference><Reference><Citation>Truzzi F., Whittaker A., D&#x2019;Amen E., Tibaldi C., Abate A., Valerii M.C., Spisni E., Dinelli G. Wheat Germ Spermidine and Clove Eugenol in Combination Stimulate Autophagy In Vitro Showing Potential in Supporting the Immune System against Viral Infections. Molecules. 2022;27:3425. doi: 10.3390/molecules27113425.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27113425</ArticleId><ArticleId IdType="pmc">PMC9182079</ArticleId><ArticleId IdType="pubmed">35684363</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomaa A.A., Abdel-Wadood Y.A., Gomaa M.A. Glycyrrhizin and Boswellic Acids, the Golden Nutraceuticals: Multitargeting for Treatment of Mild&#x2013;Moderate COVID-19 and Prevention of Post-COVID Cognitive Impairment. Inflammopharmacology. 2022;30:1977&#x2013;1992. doi: 10.1007/s10787-022-01062-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-022-01062-3</ArticleId><ArticleId IdType="pmc">PMC9493173</ArticleId><ArticleId IdType="pubmed">36136251</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Yang D., Gao X., Ju M., Fang H., Yan Z., Qu H., Zhang Y., Xie L., Weng H., et al. Ginger Supplement Significantly Reduced Length of Hospital Stay in Individuals with COVID-19. Nutr. Metab. 2022;19:84. doi: 10.1186/s12986-022-00717-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12986-022-00717-w</ArticleId><ArticleId IdType="pmc">PMC9795954</ArticleId><ArticleId IdType="pubmed">36578045</ArticleId></ArticleIdList></Reference><Reference><Citation>Khubber S., Hashemifesharaki R., Mohammadi M., Gharibzahedi S.M.T. Garlic (Allium Sativum L.): A Potential Unique Therapeutic Food Rich in Organosulfur and Flavonoid Compounds to Fight with COVID-19. Nutr. J. 2020;19:124. doi: 10.1186/s12937-020-00643-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12937-020-00643-8</ArticleId><ArticleId IdType="pmc">PMC7673072</ArticleId><ArticleId IdType="pubmed">33208167</ArticleId></ArticleIdList></Reference><Reference><Citation>Donma M.M., Donma O. The Effects of Allium Sativum on Immunity within the Scope of COVID-19 Infection. Med. Hypotheses. 2020;144:109934. doi: 10.1016/j.mehy.2020.109934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109934</ArticleId><ArticleId IdType="pmc">PMC7265825</ArticleId><ArticleId IdType="pubmed">32512493</ArticleId></ArticleIdList></Reference><Reference><Citation>Thuy B.T.P., My T.T.A., Hai N.T.T., Hieu L.T., Hoa T.T., Thi Phuong Loan H., Triet N.T., Anh T.T.V., Quy P.T., Tat P.V., et al. Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil. ACS Omega. 2020;5:8312&#x2013;8320. doi: 10.1021/acsomega.0c00772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.0c00772</ArticleId><ArticleId IdType="pmc">PMC7123907</ArticleId><ArticleId IdType="pubmed">32363255</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Wu Y., Fu P., Zhou H., Guo X., Zhu C., Tu Y., Wang J., Li H., Chen Z. Effect of Garlic Essential Oil in 97 Patients Hospitalized with COVID-19: A Multi-Center Experience. Pak. J. Pharm. Sci. 2022;35:1077&#x2013;1082.</Citation><ArticleIdList><ArticleId IdType="pubmed">36008904</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammoudi Halat D., Krayem M., Khaled S., Younes S. A Focused Insight into Thyme: Biological, Chemical, and Therapeutic Properties of an Indigenous Mediterranean Herb. Nutrients. 2022;14:2104. doi: 10.3390/nu14102104.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14102104</ArticleId><ArticleId IdType="pmc">PMC9147557</ArticleId><ArticleId IdType="pubmed">35631245</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni S.A., Nagarajan S.K., Ramesh V., Palaniyandi V., Selvam S.P., Madhavan T. Computational Evaluation of Major Components from Plant Essential Oils as Potent Inhibitors of SARS-CoV-2 Spike Protein. J. Mol. Struct. 2020;1221:128823. doi: 10.1016/j.molstruc.2020.128823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molstruc.2020.128823</ArticleId><ArticleId IdType="pmc">PMC7334662</ArticleId><ArticleId IdType="pubmed">32834111</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilokthornsakul W., Kosiyaporn R., Wuttipongwaragon R., Dilokthornsakul P. Potential Effects of Propolis and Honey in COVID-19 Prevention and Treatment: A Systematic Review of in Silico and Clinical Studies. J. Integr. Med. 2022;20:114&#x2013;125. doi: 10.1016/j.joim.2022.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joim.2022.01.008</ArticleId><ArticleId IdType="pmc">PMC8801981</ArticleId><ArticleId IdType="pubmed">35144898</ArticleId></ArticleIdList></Reference><Reference><Citation>Berretta A.A., Silveira M.A.D., C&#xf3;ndor Capcha J.M., De Jong D. Propolis and Its Potential against SARS-CoV-2 Infection Mechanisms and COVID-19 Disease: Running Title: Propolis against SARS-CoV-2 Infection and COVID-19. Biomed. Pharm. 2020;131:110622. doi: 10.1016/j.biopha.2020.110622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110622</ArticleId><ArticleId IdType="pmc">PMC7430291</ArticleId><ArticleId IdType="pubmed">32890967</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali A.M., Kunugi H. Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies. Molecules. 2021;26:1232. doi: 10.3390/molecules26051232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26051232</ArticleId><ArticleId IdType="pmc">PMC7956496</ArticleId><ArticleId IdType="pubmed">33669054</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripari N., Sartori A.A., da Silva Honorio M., Conte F.L., Tasca K.I., Santiago K.B., Sforcin J.M. Propolis Antiviral and Immunomodulatory Activity: A Review and Perspectives for COVID-19 Treatment. J. Pharm. Pharm. 2021;73:281&#x2013;299. doi: 10.1093/jpp/rgaa067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpp/rgaa067</ArticleId><ArticleId IdType="pmc">PMC7928728</ArticleId><ArticleId IdType="pubmed">33793885</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorini A.C., Scorza C.A., de Almeida A.-C.G., Fonseca M.C.M., Finsterer J., Fonseca F.L.A., Scorza F.A. Antiviral Activity of Brazilian Green Propolis Extract against SARS-CoV-2 (Severe Acute Respiratory Syndrome&#x2014;Coronavirus 2) Infection: Case Report and Review. Clin. Sao Paulo. 2021;76:e2357. doi: 10.6061/clinics/2021/e2357.</Citation><ArticleIdList><ArticleId IdType="doi">10.6061/clinics/2021/e2357</ArticleId><ArticleId IdType="pmc">PMC7811834</ArticleId><ArticleId IdType="pubmed">33503192</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachevski D., Damevska K., Simeonovski V., Dimova M. Back to the Basics: Propolis and COVID-19. Derm. Ther. 2020;33:e13780. doi: 10.1111/dth.13780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dth.13780</ArticleId><ArticleId IdType="pmc">PMC7300491</ArticleId><ArticleId IdType="pubmed">32506775</ArticleId></ArticleIdList></Reference><Reference><Citation>Bako A.T., Pan A., Potter T., Tannous J., Johnson C., Baig E., Meeks J., Woo D., Vahidy F.S. Contemporary Trends in the Nationwide Incidence of Primary Intracerebral Hemorrhage. Stroke. 2022;53:e70&#x2013;e74. doi: 10.1161/STROKEAHA.121.037332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.121.037332</ArticleId><ArticleId IdType="pubmed">35109682</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;nig S., Hohenstein S., Leiner J., Hindricks G., Meier-Hellmann A., Kuhlen R., Bollmann A. National Mortality Data for Germany before and throughout the Pandemic: There Is an Excess Mortality Exceeding COVID-19-Attributed Fatalities. J. Infect. 2022;84:834&#x2013;872. doi: 10.1016/j.jinf.2022.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.02.024</ArticleId><ArticleId IdType="pmc">PMC8881804</ArticleId><ArticleId IdType="pubmed">35231486</ArticleId></ArticleIdList></Reference><Reference><Citation>Government of Canada, Statistics Canada  Provisional Deaths and Excess Mortality in Canada Dashboard.  [(accessed on 1 October 2022)]; Available online:  https://www150.statcan.gc.ca/n1/pub/71-607-x/71-607-x2021028-eng.htm.</Citation></Reference><Reference><Citation>Aaby P., Jensen H., Gomes J., Fernandes M., Lisse I.M. The Introduction of Diphtheria-Tetanus-Pertussis Vaccine and Child Mortality in Rural Guinea-Bissau: An Observational Study. Int. J. Epidemiol. 2004;33:374&#x2013;380. doi: 10.1093/ije/dyh005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyh005</ArticleId><ArticleId IdType="pubmed">15082643</ArticleId></ArticleIdList></Reference><Reference><Citation>Ald&#xe9;n M., Olofsson Falla F., Yang D., Barghouth M., Luan C., Rasmussen M., De Marinis Y. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 MRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 2022;44:1115&#x2013;1126. doi: 10.3390/cimb44030073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cimb44030073</ArticleId><ArticleId IdType="pmc">PMC8946961</ArticleId><ArticleId IdType="pubmed">35723296</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>